<SEC-DOCUMENT>0001140361-22-036744.txt : 20221011
<SEC-HEADER>0001140361-22-036744.hdr.sgml : 20221011
<ACCEPTANCE-DATETIME>20221011083019
ACCESSION NUMBER:		0001140361-22-036744
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20221011
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20221011
DATE AS OF CHANGE:		20221011

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Brooklyn ImmunoTherapeutics, Inc.
		CENTRAL INDEX KEY:			0000748592
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				311103425
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11460
		FILM NUMBER:		221302448

	BUSINESS ADDRESS:	
		STREET 1:		140 58TH STREET, BUILDING A
		STREET 2:		SUITE 2100
		CITY:			BROOKLYN
		STATE:			NY
		ZIP:			11220
		BUSINESS PHONE:		(212) 582-1199

	MAIL ADDRESS:	
		STREET 1:		140 58TH STREET, BUILDING A
		STREET 2:		SUITE 2100
		CITY:			BROOKLYN
		STATE:			NY
		ZIP:			11220

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NTN BUZZTIME INC
		DATE OF NAME CHANGE:	20051230

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NTN COMMUNICATIONS INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ALROY INDUSTRIES INC
		DATE OF NAME CHANGE:	19850411
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>brhc10042808_8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:btx="http://brooklynitx.com/20221011" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 22.10.1.5080
         Copyright 1995 - 2022 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html" />
</head>

<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_f4c74f3a50114068b8fc6df280953aa1" contextRef="c20221011to20221011" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric name="dei:CurrentFiscalYearEndDate" id="Fact_0c42e9fbb1a94d67bd4fe2061ffa4b4a" contextRef="c20221011to20221011" format="ixt:date-month-day">12-31</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_98d859a654154548904d5bc925c4d2d2" contextRef="c20221011to20221011">0000748592</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="btx-20221011.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c20221011to20221011"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-11</xbrli:startDate><xbrli:endDate>2022-10-11</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>

  <div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div>

  <div>
    <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" />
    <div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">UNITED STATES</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;">Washington, D.C. 20549</div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
        </span></div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 18pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_74af326254b54e3ea3b1f90a4a82d9c1" contextRef="c20221011to20221011">8-K</ix:nonNumeric></div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
        </span></div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CURRENT REPORT</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
        </span></div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_d4e40098caee47eeac575a40fc534cd3" contextRef="c20221011to20221011" format="ixt:date-monthname-day-year-en">October 11, 2022</ix:nonNumeric></div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: center; font-size: 24pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_d6ca176d43b54f5ca44ffa3fb23a053b" contextRef="c20221011to20221011">Brooklyn ImmunoTherapeutics, Inc.</ix:nonNumeric></div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">(Exact Name of Registrant as Specified in its Charter)</div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
        </span></div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 32.61%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; text-align: center;"><span style="font-weight: bold;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_02b28958ec194c53a4cddd03a9ca151b" contextRef="c20221011to20221011" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span><br />
            </td>

    <td style="width: 33.68%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; text-align: center;"><span style="font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_f0d9dd2225764eaaa6ba9952f0e3440a" contextRef="c20221011to20221011">001-11460</ix:nonNumeric></span><br />
            </td>

    <td style="width: 33%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; text-align: center;"><span style="font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_4c46da281ba54cbcbfeb92ad2fe81f0f" contextRef="c20221011to20221011">31-1103425</ix:nonNumeric></span><br />
            </td>

  </tr>

  <tr>

    <td style="width: 32.61%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; font-style: italic;">(State or Other Jurisdiction of Incorporation)</div>
            </td>

    <td style="width: 33.68%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; font-style: italic;">(Commission File Number)</div>
            </td>

    <td style="width: 33%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; font-style: italic;">(IRS Employer Identification No.)</div>
            </td>

  </tr>


</table>
      <div><span style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
        </span> </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 49.01%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_5b11d15cab4a4b519cf8e6946af70c20" contextRef="c20221011to20221011">10355 Science Center Drive</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" id="Fact_cbc19756eeee43c797358ae8a49fb202" contextRef="c20221011to20221011">Suite 150</ix:nonNumeric></div>
            </td>

    <td style="width: 2%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 49%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 49.01%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_34112a7a0efb47138fd2329af1e48d97" contextRef="c20221011to20221011">San Diego</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_527b3f309abe452db9d915551f843097" contextRef="c20221011to20221011" format="ixt-sec:stateprovnameen">California</ix:nonNumeric></div>
            </td>

    <td style="width: 2%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 49%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; text-align: center;"><span style="font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_255037ece31343c5a7beac9c081249c6" contextRef="c20221011to20221011">92121</ix:nonNumeric></span><br />
            </td>

  </tr>

  <tr>

    <td style="width: 49.01%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; font-style: italic;">(Address of Principal Executive Offices)</div>
            </td>

    <td style="width: 2%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 49%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; font-style: italic;">(Zip Code)</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Registrant&#8217;s telephone number, including area code: <span style="font-weight: bold;">(<ix:nonNumeric name="dei:CityAreaCode" id="Fact_0ad11d08743740f9949d326f407762e5" contextRef="c20221011to20221011">212</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_95ae2803545845cca7bc14c11e9213a4" contextRef="c20221011to20221011">582-1199</ix:nonNumeric></span></div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
        provisions:</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_fc126e0906934d6cb9a6593b2ed042b0" contextRef="c20221011to20221011" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_546bff35ea714b3daff1c3783d3da515" contextRef="c20221011to20221011" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_61afcada52944ec5b08b921acb8176bc" contextRef="c20221011to20221011" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_19e91ba63e804c2db51df991aa0d9cd5" contextRef="c20221011to20221011" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 41.3%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; font-weight: bold;">Title of each class</div>
            </td>

    <td style="width: 0.96%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 18.76%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; font-weight: bold;">Trading symbol</div>
            </td>

    <td style="width: 2%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 36.98%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; font-weight: bold;">Name of each exchange on which registered</div>
            </td>

  </tr>

  <tr>

    <td style="width: 41.3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_146d02dd6ad44a9ea067d3464fc340b0" contextRef="c20221011to20221011">Common Stock, par value $0.005 per share</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 0.96%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 18.76%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; text-align: center;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_0a298397c4b24d1dbe4048c10c25863e" contextRef="c20221011to20221011">BTX</ix:nonNumeric><br />
            </td>

    <td style="width: 2%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 36.98%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; text-align: center;"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_6c4d5357ecc64860a44eff1dbe9d85e8" contextRef="c20221011to20221011" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric><br />
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities
        Exchange Act of 1934:</div>

      <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_dbe7ed8b6c534e27948be6d820d5f6ba" contextRef="c20221011to20221011" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
        financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
      </div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
        <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" /> </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 54pt; vertical-align: top; text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 5.03</td>

    <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Name Change</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">The board of directors (the &#8220;<span style="text-decoration: underline;">Board</span>&#8221;) of Brooklyn ImmunoTherapeutics, Inc., a
          Delaware corporation (the &#8220;<span style="text-decoration: underline;">Company</span>&#8221;), approved an amendment to the Company&#8217;s Restated Certificate of Incorporation, as amended (the &#8220;<span style="text-decoration: underline;">Charter</span>&#8221;), to change the Company&#8217;s name to </span><span style="font-family: 'Times New Roman'; font-size: 10pt;">Eterna Therapeutics<span style="color: rgb(0, 0, 0);"> Inc. (the &#8220;</span><span style="text-decoration: underline;">Name</span><span style="color: rgb(0, 0, 0);"><span style="text-decoration: underline;">&#160;</span></span><span style="text-decoration: underline;">Change</span><span style="color: rgb(0, 0, 0);">&#8221;). On October 11, 2022, the Company filed </span>with


          the Secretary of State of the State of Delaware a <span style="color: rgb(0, 0, 0);">Certificate of Amendment (the &#8220;<span style="text-decoration: underline;">Name Change Charter Amendment</span>&#8221;) to the Charter, which will effect the Name Change at 12:01 a.m. on October 17, 2022.
            Pursuant to Section 242(b)(1) of the General Corporation Law of the State of Delaware, the Name Change did not require approval of the Company&#8217;s stockholders and will not affect the rights of the Company&#8217;s security holders.</span></span></div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Additionally, the Board approved an amendment to the Company&#8217;s bylaws solely to reflect the Name Change (the &#8220;<span style="text-decoration: underline;">Amended and Restated Bylaws</span>&#8221;).


        The Amended and Restated Bylaws will become effective immediately after the Name Change on October 17, 2022.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Reverse Stock Split</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">On <span style="color: rgb(0, 0, 0);">October 11, 2022</span>, the Company filed a Certificate of Amendment to its Charter (the &#8220;<span style="text-decoration: underline;">Reverse Stock Split Charter
          Amendment</span>&#8221;) with the Secretary of State of the State of Delaware to effect a reverse stock split of the Company&#8217;s common stock, par value $0.005 per share (the &#8220;<span style="text-decoration: underline;">common stock</span>&#8221;), at a ratio of 1-for-20, which will become effective at <span style="color: rgb(0, 0, 0);">11:59 p.m. Eastern Time on October 16, 2022 (the &#8220;<span style="text-decoration: underline;">Reverse Stock Split</span>&#8221;)</span>.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The foregoing description of the Name Change, the Amended and Restated Bylaws and the Reverse Stock Split is only a summary and is qualified in
        its entirety by reference to the full text of the Name Change Charter Amendment, the Amended and Restated Bylaws and the Reverse Stock Split Charter Amendment, respectively, which are filed as Exhibits 3.1, 3.2 and 3.3, respectively, to this
        Current Report on Form 8-K and are incorporated by reference herein.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 54pt; vertical-align: top; text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 8.01</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Other Events.</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">As previously reported, at the Company&#8217;s Annual Meeting of Stockholders held on September 21, 2022, the Company&#8217;s stockholders approved an amendment to the Charter to
        <span style="color: rgb(0, 0, 0);">effect the Reverse Stock Split at a ratio of 1-for-10 to 1-for-20 to be determined at the discretion of the Board. T</span>he Board subsequently determined to set the Reverse Stock Split ratio at 1-for-20 and
        approved and authorized the filing of the Reverse Stock Split Charter Amendment. The effective time for the <span style="color: rgb(0, 0, 0);">Reverse Stock Split</span> under Delaware law is 11:59 p.m. Eastern time on <span style="color: rgb(0, 0, 0);">October 16, 2022</span>. The common stock is expected to begin trading on a split-adjusted basis at market open of Nasdaq on <span style="color: rgb(0, 0, 0);">October 17, 2022</span>.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Upon the effectiveness of the <span style="color: rgb(0, 0, 0);">Reverse Stock Split</span>, every twenty shares of the issued and outstanding common stock will be
        automatically combined and reclassified into one issued and outstanding share of common stock. The <span style="color: rgb(0, 0, 0);">Reverse Stock Split</span> does not affect any stockholder&#8217;s ownership percentage of the common stock, alter the
        par value of the common stock or modify any voting rights or other terms of the common stock.&#160; <span style="color: rgb(0, 0, 0);">The number of authorized shares of common stock under the Charter remains unchanged. No fractional shares will be
          issued in connection with the Reverse Stock Split. In lieu of any fractional shares to which a stockholder would otherwise be entitled, the Company will pay an amount of cash equal to the product of (i) the fractional share to which the holder
          would otherwise be entitled and (ii) the then fair value of a share as determined in good faith by the Board.</span></div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">The Company&#8217;s transfer agent, <span style="color: rgb(0, 0, 0);">Computershare Trust Company, N.A</span>, is acting as exchange agent for the Reverse Stock Split and
        will send instructions to stockholders of record regarding the exchange of certificates for common stock.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">At the market open on <span style="color: rgb(0, 0, 0);">October 17, 2022</span>, the Company&#8217;s common stock will continue to trade on The Nasdaq Global Market, but,
        in connection with the Name Change, under the symbol &#8220;<span style="color: rgb(0, 0, 0);">ERNA</span>,&#8221; and, in connection with the Reverse Stock Split, the common stock will be assigned a new CUSIP number (<span style="color: rgb(0, 0, 0);">114082
          209) when it begins trading</span> on a split-adjusted basis.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 54pt; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 9.01</td>

    <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="font-weight: bold;">Financial Statements and Exhibits.</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">(d) Exhibits.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 12.36%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit</div>
                <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Number</div>
              </div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; padding-bottom: 2px;">&#160;</td>

    <td style="width: 87%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: center;">
              <div>
                <div style="font-weight: bold;">Description</div>
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 12.36%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;"><a href="brhc10042808_ex3-1.htm">3.1</a></div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 87%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: justify;">Certificate of Amendment to the Company&#8217;s <span style="color: rgb(0, 0, 0);">Restated Certificate of Incorporation</span>, filed October 11, 2022 (Name Change).</div>
            </td>

  </tr>

  <tr>

    <td style="width: 12.36%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;"><a href="brhc10042808_ex3-2.htm">3.2</a></div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 87%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: justify;">Second Amended and Restated Bylaws of the Company</div>
            </td>

  </tr>

  <tr>

    <td style="width: 12.36%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;"><a href="brhc10042808_ex3-3.htm">3.3</a></div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 87%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: justify;">Certificate of Amendment to the Company&#8217;s <span style="color: rgb(0, 0, 0);">Restated Certificate of Incorporation</span>, filed October 11, 2022 (Reverse Stock Split).</div>
            </td>

  </tr>

  <tr>

    <td style="width: 12.36%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">104</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 87%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: justify;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      </div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SIGNATURE</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto
        duly authorized.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 49.72%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="3" style="vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; font-variant: small-caps;">Brooklyn ImmunoTherapeutics, Inc.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 49.72%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="3" style="vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 49.72%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;">Dated: October 11<span style="color: rgb(0, 0, 0);">, 2022</span></div>
            </td>

    <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;">By:</div>
            </td>

    <td style="width: 46%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;">/s/ Andrew Jackson</div>
            </td>

    <td style="width: 1.01%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 49.72%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 46%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;">Chief Financial Officer</div>
            </td>

    <td style="width: 1.01%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
<div><br /></div>

        <div>
          <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

      </div>

    </div>

  </div>

  <div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>brhc10042808_ex3-1.htm
<DESCRIPTION>EXHIBIT 3.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc
         Document created using Broadridge PROfile 22.10.1.5080
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <font style="font-size: 10pt;"> </font>
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right; margin-right: 2pt; margin-left: 145.3pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit 3.1</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CERTIFICATE OF AMENDMENT OF</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">RESTATED CERTIFICATE OF INCORPORATION OF</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">BROOKLYN IMMUNOTHERAPEUTICS, INC.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 35.95pt; margin-left: 5pt; font-family: 'Times New Roman'; font-size: 10pt;">Brooklyn ImmunoTherapeutics, Inc. (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Corporation</font>&#8221;),

        a Delaware corporation, does hereby certify that:</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 31pt; margin-left: 5pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">1.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">The certificate of
            incorporation of the Corporation is hereby amended by deleting Article I thereof in its entirety and inserting the following in lieu thereof:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">&#8220;The name of the corporation (the &#8220;Corporation&#8221;) is Eterna Therapeutics Inc.&#8221;</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 31pt; margin-right: 5.85pt; margin-left: 5pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">The

            amendment set forth in this Certificate of Amendment has been duly adopted in accordance with Section 242 of the General Corporation Law of the State of Delaware.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 31pt; margin-left: 5pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">3.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">This Certificate of
            Amendment shall be effective on October 17, 2022 at 12:01 a.m. Eastern Time.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">[Remainder of Page Intentionally Left Blank]</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%%%-->&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; IN WITNESS WHEREOF, the Corporation has caused this Certificate to be executed and acknowledged on October 11, 2022.
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" id="zdbe4ea11293348409dcf0336cde2aca3" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="vertical-align: top; font-size: 10pt;" colspan="3">
              <div style="text-align: left; font-family: 'Times New Roman';">BROOKLYN IMMUNOTHERAPEUTICS, INC.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;">&#160;</td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;">
              <div style="text-align: left; margin-right: 6pt; font-family: 'Times New Roman';">By:</div>
            </td>
            <td style="width: 30%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; margin-right: 6pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">/s/</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Matthew Angel</font></div>
            </td>
            <td style="width: 17%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 6pt; font-family: 'Times New Roman';">Matthew Angel, Interim Chief Executive Officer and President</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="font-size: 10pt; text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">2</font></div>
      <div style="font-size: 10pt;">
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
  <font style="font-size: 10pt;"> </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.2
<SEQUENCE>3
<FILENAME>brhc10042808_ex3-2.htm
<DESCRIPTION>EXHIBIT 3.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc
         Document created using Broadridge PROfile 22.10.1.5080
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <font style="font-size: 10pt;">
  </font>
  <div style="text-align: right;">
    <hr noshade="noshade" style="height: 4px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); margin-left: auto; margin-right: auto; border: medium none;">
    <div><font style="font-weight: bold; font-size: 10pt;">Exhibit 3.2<br>
      </font></div>
    <div style="text-align: left;">
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">BYLAWS</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">OF</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ETERNA THERAPEUTICS INC.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(as amended and restated through October 17, 2022)</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SECOND AMENDED AND RESTATED</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">BYLAWS</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">OF</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ETERNA THERAPEUTICS INC.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Effective October 17, 2022</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CORPORATE OFFICES</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zb87374cade1b4257bcb411fd9eb6041e" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">1.1</td>
            <td style="vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman'; font-weight: bold;"><u>Registered Office.</u></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">The registered office of the Corporation shall be in the City of Wilmington, County of New Castle, State of Delaware. The name of the registered
        agent of the Corporation at such location is Corporate Agents, Inc.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z1bab45f3166f457b9f953a9ae408194e" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">1.2</td>
            <td style="vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman'; font-weight: bold;"><u>Other Offices.</u></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Board of Directors may at any time establish other offices at any place or places where the Corporation is qualified to do business.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">MEETINGS OF STOCKHOLDERS</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z542ebda0404a41b58bafe6cff98d3721" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2.1</td>
            <td style="vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman'; font-weight: bold;"><u>Annual Meetings.</u></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">The annual meeting of the stockholders of the Corporation, for the purpose of election of directors and for such other business as may lawfully come
        before it, shall be held on such date and at such time as may be designated from time to time by the Board of Directors. The Board of Directors may, in its sole discretion, determine that the meeting may be held solely by means of remote
        communication, as permitted by Section&#160; 211 of the Delaware General Corporation Law (the &#8220;DGCL&#8221;).</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">At an annual meeting of the stockholders, only such business shall be conducted as shall have been properly brought before the meeting. To be
        properly brought before an annual meeting, business must be: (A)&#160; specified in the notice of meeting (or any supplement thereto) given by or at the direction of the Board of Directors, (B)&#160; otherwise properly brought before the meeting by or at the
        direction of the Board of Directors, or (C)&#160; otherwise properly brought before the meeting by a stockholder. For business to be properly brought before an annual meeting by a stockholder, the stockholder must have given timely notice thereof in
        writing to the Secretary of the Corporation. To be timely, (1)&#160; with respect to the 2007 annual meeting of the stockholder&#8217;s a stockholder&#8217;s notice must be delivered to or mailed and received at the principal executive offices of the Corporation no
        later than the date that is ninety (90)&#160; calendar days in advance of the anniversary date of the 2006 annual meeting of stockholders, and (2)&#160; with respect to annual meetings of stockholders beginning in 2008 and for years thereafter, a
        stockholder&#8217;s notice must be delivered to or mailed and received at the principal executive offices of the Corporation no later than the date specified in the Corporation&#8217;s proxy statement released to stockholders in connection with the previous
        year&#8217;s annual meeting of stockholders, which date shall be not less than ninety (90)&#160; or more than one hundred twenty (120)&#160; calendar days in advance of the anniversary of the date of such previous year&#8217;s proxy statement; provided, however, that if
        the date of the annual meeting is advanced more than 30 days before or delayed by more than 30 days after the anniversary of the preceding year&#8217;s annual meeting, or if the Corporation did not hold an annual meeting in the preceding year, notice by
        the stockholder to be timely must be so delivered not later than the close of business on the later of the 90th day before such annual meeting or the 10th day following the day on which public announcement of the date of such meeting is first made.
        A stockholder&#8217;s notice to the Secretary shall set forth as to each matter the stockholder proposes to bring before the annual meeting: (i)&#160; a brief description of the business desired to be brought before the annual meeting and the reasons for
        conducting such business at the annual meeting, (ii)&#160; the name and address, as they appear on the Corporation&#8217;s books, of the stockholder proposing such business, (iii)&#160; the class and number of shares of the Corporation which are beneficially owned
        by the stockholder, (iv)&#160; any material interest of the stockholder in such business and (v)&#160; any other information that is required to be provided by the stockholder pursuant to Regulation 14A under the Securities Exchange Act of 1934, as amended
        (the &#8220;Exchange Act&#8217;&#8221;), in his capacity as a proponent to a stockholder proposal. In addition to the foregoing, in order to include information with respect to a stockholder proposal in the proxy statement and form of proxy for a stockholders&#8217;
        meeting, stockholders must provide notice as required by the regulations promulgated under the Exchange Act to the extent such regulations require notice that is different from the notice required above. Notwithstanding anything in these Bylaws to
        the contrary, no business shall be conducted at any annual meeting except in accordance with the procedures set forth in this paragraph (b)&#160; of this Section&#160; 2.1. The chairman of the meeting shall have the power and the duty to determine whether
        any business proposed to be brought before the meeting has been made in accordance with the procedures set forth in these Bylaws and, if any proposed business is not in compliance with these Bylaws, to declare that such defectively proposed
        business shall not be presented for stockholder action at the meeting and shall be disregarded.</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%%%-->
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">Only persons who are nominated in accordance with the procedures set forth in this paragraph (c)&#160; shall be eligible for election as directors.
        Nominations of persons for election to the Board of Directors of the Corporation may be made at a meeting of stockholders by or at the direction of the Board of Directors or by any stockholder of the Corporation entitled to vote in the election of
        directors at the meeting who complies with the notice procedures set forth in this paragraph (c). Such nominations, other than those made by or at the direction of the Board of Directors, shall be made pursuant to timely notice in writing to the
        Secretary of the Corporation in accordance with the provisions of paragraph (b)&#160; of this Section&#160; 2.1. Such stockholder&#8217;s notice shall set forth (i)&#160; as to each person, if any, whom the stockholder proposes to nominate for election or re-election
        as a director: (A)&#160; the name, age, business address and residence address of such person, (B)&#160; the principal occupation or employment of such person, (C)&#160; the class and number of shares of the Corporation that are beneficially owned by such person,
        (D)&#160; a description of all arrangements or understandings between the stockholder and each nominee and any other person or persons (naming such person or persons) pursuant to which the nominations</div>
      <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';"> </font><font style="font-size: 10pt;"><br>
        </font></div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">are to be made by the stockholder, and (E)&#160; any other information relating to such person that is required to be disclosed in solicitations of proxies for election of
        directors, or is otherwise required, in each case pursuant to Regulation 14A under the Exchange Act (including without limitation such person&#8217;s written consent to being named in the proxy statement, if any, as a nominee and to serving as a director
        if elected); and (ii)&#160; as to such stockholder giving notice, the information required to be provided pursuant to subitems (ii), (iii)&#160; and (iv)&#160; of paragraph (b)&#160; of this Section&#160; 2.1. At the request of the Board of Directors, any person nominated
        by a stockholder for election as a director shall furnish to the Secretary of the Corporation that information required to be set forth in the stockholder&#8217;s notice of nomination which pertains to the nominee. No person shall be eligible for
        election as a director of the Corporation unless nominated in accordance with the procedures set forth in this paragraph (c). The chairman of the meeting shall have the power and the duty to determine whether a nomination has been made in
        accordance with the procedures set forth in these Bylaws and, if any proposed nomination is not in compliance with these Bylaws, to declare that such defectively proposed nomination shall not be presented for stockholder action at the meeting and
        shall be disregarded.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">Nothing in this Section&#160; 2.1 shall be deemed to affect any rights of stockholders to request inclusion of proposals in the Corporation&#8217;s proxy
        statement pursuant to Rule 14a-8 under the Exchange Act.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zb24f4851533e4ce69cb25feacc8397a8" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2.2</td>
            <td style="vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman'; font-weight: bold;"><u>Special Meetings.</u></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">Special meetings of the stockholders, other than those required by statute, may be called at any time by the Board of Directors acting pursuant to a
        resolution adopted by a majority of the Whole Board. For purposes of these Bylaws, the term &#8220;Whole Board&#8221; shall mean the total number of authorized directors whether or not there exist any vacancies in previously authorized directorships. The Board
        of Directors may postpone or reschedule any previously scheduled special meeting.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">Only such business shall be conducted at a special meeting of the stockholders as shall have been brought before the meeting pursuant to the
        Corporation&#8217;s notice of the meeting.</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">2</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">Nominations of persons for election to the Board of Directors may be made at a special meeting of stockholders at which directors are to be elected
        pursuant to the Corporation&#8217;s notice of meeting (i)&#160; by or at the direction of the Board of Directors or (ii)&#160; by any stockholder of record at the time of giving of notice provided for in this paragraph, who shall be entitled to vote at the meeting
        and who complies with the notice procedures set forth in this Section&#160; 2.2. Nominations by stockholders of persons for election to the Board of Directors may be made at such a special meeting of stockholders if the stockholder&#8217;s notice has been
        delivered to the Secretary at the principal executive offices of the Corporation not later than the close of business on the later of the 90th day before such special meeting or the 10th day following the day on which public announcement is first
        made of the date of the special meeting and of the nominees proposed by the Board of Directors to be elected at such meeting.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">Nothing in this Section&#160; 2.2 shall be deemed to affect any rights of stockholders to request inclusion of proposals in the Corporation&#8217;s proxy
        statement pursuant to Rule 14a-8 under the Exchange Act.</div>
      <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';"> </font><font style="font-size: 10pt;"><br>
        </font></div>
      <table cellspacing="0" cellpadding="0" id="z18a2a9633e924f7ab239921e89923690" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2.3</td>
            <td style="vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman'; font-weight: bold;"><u>Notice of Stockholders&#8217; Meetings.</u></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">Notice of the place, if any, date and time of all meetings of stockholders, and the means of remote communication, if any, by which stockholders and
        proxy holders may be deemed to be present and person and vote at such meeting, shall be given not less than 10 nor more than 60 days before the date of the meeting to each stockholder entitled to vote at such meeting, except as otherwise provided
        herein or required by law or the Certificate of Incorporation. Written notice of any meeting of stockholders, if mailed, is given when deposited in the United States mail, postage prepaid, directed to the stockholder at his address as it appears on
        the records of the Corporation. Without limiting the manner by which notice otherwise may be given effectively to stockholders, any notice to stockholders may be given by electronic mail or other electronic transmission, in the manner provided in
        Section&#160; 232 of the DGCL. An affidavit of the secretary or an assistant secretary or of the transfer agent of the Corporation that the notice has been given shall, in the absence of fraud, be prima facie evidence of the facts stated therein.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">When a meeting is adjourned to another time or place, notice need not be given of the adjourned meeting if the time and place, if any, thereof, and
        the means of remote communications, if any, by which stockholders and proxy holders may be deemed to be present in person and vote at such adjourned meeting are announced at the meeting at which the adjournment is taken; provided, however, that if
        the date of any adjourned meeting is more than 30 days after the date for which the meeting was originally noticed, or if a new record date is fixed for the adjourned meeting, notice of the place, if any, date, and time of the adjourned meeting and
        the means of remote communications, if any, by which stockholders and proxy holders may be deemed to be present in person and vote at such adjourned meeting, shall be given in conformity herewith. At any adjourned meeting, any business may be
        transacted which might have been transacted at the original meeting.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z92a4ac4822654edc8faab7803cd07a9e" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2.4</td>
            <td style="vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Quorum</u></font><font style="font-size: 10pt;">.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">At any meeting of the stockholders, the holders of a majority of the shares of stock entitled to vote at the meeting, present in person or by proxy,
        shall constitute a quorum for all purposes, except as otherwise provided by the DGCL or by the Certificate of Incorporation. Where a separate vote by a class or classes or series is required, a majority of the shares of such class or classes or
        series present in person or by proxy shall constitute a quorum entitled to take action with respect to that vote on that matter.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">If a quorum shall fail to attend any meeting, the chairman of the meeting may adjourn the meeting to another place, if any, date or time.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zfbb706a2404640b995782d379c2aa1e3" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2.5</td>
            <td style="vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Organization; Conduct of Business</u></font><font style="font-size: 10pt;">.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">The chief executive officer of the Corporation or, if no such officer has been appointed or in his or her absence, the president of the Corporation
        or, in his or her absence, the chairman of the Board of Directors, shall call to order any meeting of the stockholders and act as chairman of the meeting. In the absence of the secretary of the Corporation, the secretary of the meeting shall be
        such person as the chairman of the meeting appoints.</div>
      <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';"> </font><font style="font-size: 10pt;"><br>
        </font></div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">The chairman of any meeting of stockholders shall determine the order of business and the procedure at the meeting, including the manner of voting
        and the conduct of business. The chairman shall have the power to adjourn the meeting to another place, if any, date and time. The date and time of opening and closing of the polls for each matter upon which the stockholders will vote at the
        meeting shall be announced at the meeting.</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">3</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="ze0a2172645e346fbb5f1a17947476541" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2.6</td>
            <td style="vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman'; font-weight: bold;"><u>Proxies and Voting.</u></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">At any meeting of the stockholders, every stockholder entitled to vote may vote in person or by proxy authorized by an instrument in writing or by a
        transmission permitted by law filed in accordance with the procedure established for the meeting. Any copy, facsimile communication or other reliable reproduction of the writing or transmission created pursuant to this paragraph may be substituted
        or used in lieu of the original writing or transmission for any and all purposes for which the original writing or transmission could be used, provided that such copy, facsimile telecommunication or other reproduction shall be a complete
        reproduction of the entire original writing or transmission.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">The Corporation may, and to the extent required by law, shall, in advance of any meeting of stockholders, appoint one or more inspectors to act at
        the meeting and make a written report thereof. The Corporation may designate one or more alternate inspectors to replace any inspector who fails to act. If no inspector or alternate is able to act at a meeting of stockholders, the chairman of the
        meeting may, and to the extent required by law, shall, appoint one or more inspectors to act at the meeting. Each inspector, before entering upon the discharge of his or her duties, shall take and sign an oath faithfully to execute the duties of
        inspector with strict impartiality and according to the best of his or her ability. Every vote taken by ballots shall be counted by a duly appointed inspector or inspectors.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">All elections of directors shall be determined by a plurality of the votes cast, and except as otherwise required by law, all other matters shall be
        determined by a majority of the votes cast affirmatively or negatively.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z2821c53bd98043088425b8c80684bf5b" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2.7</td>
            <td style="vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Waiver of Notice</u></font><font style="font-size: 10pt;">.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">Whenever notice is required to be given under any provision of the DGCL or of the Certificate of Incorporation or these Bylaws, a written waiver
        thereof, signed by the person entitled to notice, or waiver by electronic mail or other electronic transmission by such person, whether before or after the time stated therein, shall be deemed equivalent to notice. Attendance of a person at a
        meeting shall constitute a waiver of notice of such meeting, except when the person attends a meeting for the express purpose of objecting, at the beginning of the meeting, to the transaction of any business because the meeting is not lawfully
        called or convened. Neither the business to be transacted at, nor the purpose of, any regular or special meeting of the stockholders need be specified in any written waiver of notice, or any waiver of notice by electronic transmission, unless so
        required by the Certificate of Incorporation or these Bylaws.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z8e4ba682c1a74e18957a1d8ee6507095" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2.8</td>
            <td style="vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman'; font-weight: bold;"><u>Record Date for Stockholder Notice.</u></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">In order that the Corporation may determine the stockholders entitled to notice of or to vote at any meeting of stockholders or any adjournment
        thereof or entitled to receive</div>
      <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';"> </font><font style="font-size: 10pt;"><br>
        </font></div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">payment of any dividend or other distribution or allotment of any rights, or entitled to exercise any rights in respect of any change, conversion or exchange of stock or
        for the purpose of any other lawful action, the Board of Directors may fix a record date, which record date shall not precede the date on which the resolution fixing the date is adopted and which record date shall not be more than 60 nor less than
        10 days before the date of such meeting, nor more than 60 days before any other action.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">If the Board of Directors does not so fix a record date:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">The record date for determining stockholders entitled to notice of or to vote at a meeting of stockholders shall be at the close of business on the
        day next preceding the day on which notice is given, or, if notice is waived, at the close of business on the day next preceding the day on which the meeting is held.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">The record date for determining stockholders for any other purpose shall be at the close of business on the day on which the Board of Directors
        adopts the resolution relating thereto.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">A determination of stockholders of record entitled to notice of or to vote at a meeting of stockholders shall apply to any adjournment of the
        meeting, if such adjournment is for 30 days or less; provided, however, that the Board of Directors may fix a new record date for the adjourned meeting.</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">4</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">DIRECTORS</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zf4d7bdaeba0f4fb0bfb043bdb4c7b18f" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">3.1</td>
            <td style="vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman'; font-weight: bold;"><u>Number of Directors.</u></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">The number of directors constituting the Whole Board shall be determined by the Board from time to time by a resolution duly adopted by the Board,
        subject to the rights of the holders of any series of preferred stock to elect directors under specified circumstances. No decrease in the number of authorized directors shall shorten the term of any incumbent director.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z61c892e525114d81978a43106c11406e" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">3.2</td>
            <td style="vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman'; font-weight: bold;"><u>Election and Term of Office of Directors.</u></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">Except as provided in Section&#160; 3.3 of these Bylaws, and unless otherwise provided in the Certificate of Incorporation, directors shall be elected at
        each annual meeting of stockholders to hold office until the next annual meeting at which the term of office of the class to which they have been elected expires. Each director, including a director elected to fill a vacancy, shall hold office
        until his or her successor is elected or until his or her earlier resignation or removal.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z05cb2c9afea1456eac6d29dc8590c308" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">3.3</td>
            <td style="vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman'; font-weight: bold;"><u>Director Resignations, Newly Created Directors and Vacancies.</u></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">Any director may resign at any time upon written notice to the attention of the secretary of the Corporation or, if there is no secretary in office,
        then to the attention of any other</div>
      <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';"> </font><font style="font-size: 10pt;"><br>
        </font></div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">corporate officer or to the Board of Directors as a whole. When one or more directors so resigns and the resignation is effective at a future date, a majority of the
        directors then in office, including those who have so resigned, shall have power to fill such vacancy or vacancies, the vote thereon to take effect when such resignation or resignations shall become effective, and each director so chosen shall hold
        office as provided in this section in the filling of other vacancies.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">Subject to the rights of the holders of any series of preferred stock then outstanding, newly created directorships resulting from any increase in
        the authorized number of directors or any vacancies in the Board of Directors resulting from death, resignation, retirement, removal from office or other cause shall, unless otherwise required by law or by resolution of the Board of Directors, be
        filled only by a majority vote of the directors then in office, though less than a quorum, and directors so chosen shall serve for a term expiring at the next annual meeting of stockholders at which the term of office of the class to which they
        have been elected expires or until such director&#8217;s successor shall have been duly elected. Unless otherwise required by law or by resolution of the Board of Directors, the stockholders shall have no right or power to fill any such vacancies or
        newly created directorships.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">Whenever the holders of any class or classes of stock or series thereof are entitled to elect one or more directors by the provisions of the
        Certificate of Incorporation, vacancies and newly created directorships of such class or classes or series may be filled by a majority of the directors elected by such class or classes or series thereof then in office, or by a sole remaining
        director so elected.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">If at any time, by reason of death or resignation or other cause, the Corporation should have no directors in office, then any officer or any
        stockholder or an executor, administrator, trustee or guardian of a stockholder, or other fiduciary entrusted with like responsibility for the person or estate of a stockholder, may call a special meeting of stockholders in accordance with the
        provisions of the Certificate of Incorporation or these Bylaws, or may apply to the Court of Chancery for a decree summarily ordering an election as provided in Section&#160; 211 of the DGCL.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">If, at the time of filling any vacancy or any newly created directorship, the directors then in office constitute less than a majority of the Whole
        Board (as constituted immediately before any such increase), then the Court of Chancery may, upon application of any stockholder or stockholders holding at least 10% of the total number of the shares at the time outstanding having the right to vote
        for such directors, summarily order an election to be held to fill any such vacancies or newly created directorships, or to replace the directors chosen by the directors then in office as aforesaid, which election shall be governed by the
        provisions of Section&#160; 211 of the DGCL as far as applicable.</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">5</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z146e4a22284d4825a20f22a7f692af99" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">3.4</td>
            <td style="vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Participation in Meetings by Conference Telephone</u></font><font style="font-size: 10pt;">.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">Members of the Board of Directors, or of any committee thereof, may participate in a meeting of the Board of Directors, or any committee, by means
        of conference telephone or other communications equipment by means of which all persons participating in the meeting can</div>
      <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';"> </font><font style="font-size: 10pt;"><br>
        </font></div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">hear each other, and such participation in a meeting shall constitute presence in person at the meeting.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z1d217a7872ae4578ab1c38f5cee3d016" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">3.5</td>
            <td style="vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Regular Meetings</u>.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">Regular meetings of the Board of Directors may be held at such place, date and time as shall from time to time be determined by the Board of
        Directors. A notice of each regular meeting shall not be required.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z764c12f9e2784d0a9fd2b72da484e5dc" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">3.6</td>
            <td style="vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Special Meetings</u>.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">Special meetings of the Board of Directors may be called by the Chairman of the Board, the president or by a majority of the Whole Board, and shall
        be held at such place, date and time as he, she or they shall fix.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">Notice of the place, date and time of special meetings shall be delivered personally or by telephone to each director or sent by first-class mail,
        charges prepaid, or by facsimile or electronic mail, addressed to each director at that director&#8217;s address as it is shown on the records of the Corporation. If the notice is mailed, it shall be deposited in the United States mail at least four days
        before the time of the holding of the meeting. If the notice is delivered personally, or by facsimile, electronic mail or telephone, it shall be delivered at least 24 hours before the time of the holding of the meeting. The notice need not specify
        the place of the meeting, if the meeting is to be held at the principal executive office of the Corporation. Any and all business may be transacted at a special meeting, unless otherwise indicated in the notice thereof.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z4e4beefa27ee4a338592b5cc5c732c34" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">3.7</td>
            <td style="vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Quorum</u>.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">At any meeting of the Board of Directors, a majority of the Whole Board shall constitute a quorum for all purposes, except as may be otherwise
        specifically provided by statute or by the Certificate of Incorporation. If a quorum shall fail to attend any meeting, then a majority of the directors present may adjourn the meeting to another place, date or time, without further notice or waiver
        thereof.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">A meeting at which a quorum is initially present may continue to transact business notwithstanding the withdrawal of directors, if any action taken
        is approved by at least a majority of the required quorum for that meeting.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z414f5e17cf4841e6a90f0ece5ec0af97" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">3.8</td>
            <td style="vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Waiver of Notice</u>.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">Whenever notice of a Board of Directors meeting is required to be given under any provision of the DGCL or of the Certificate of Incorporation or
        these Bylaws, a written waiver thereof, signed by the person entitled to notice, or waiver by electronic mail or other electronic transmission by such person, whether before or after the time stated therein, shall be deemed equivalent to notice.
        Attendance of a person at a meeting shall constitute a waiver of notice of such meeting, except when the person attends a meeting for the express purpose of objecting, at the beginning of the meeting, to the transaction of any business because the
        meeting is not lawfully called or convened. Neither the business to be transacted at, nor the purpose of,</div>
      <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';"> </font><font style="font-size: 10pt;"><br>
        </font></div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">any regular or special meeting of the directors, or members of a committee of directors, need be specified in any written waiver of notice or any waiver by electronic
        transmission unless so required by the Certificate of Incorporation or these Bylaws.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="ze58236fb14994dcd88714898d9468374" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">3.9</td>
            <td style="vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Conduct of Business; Board Action by Written Consent Without a Meeting</u>.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">At any meeting of the Board of Directors, business shall be transacted in such order and manner as the Board of Directors may from time to time
        determine, and all matters shall be determined by the vote of a majority of the directors present, except as otherwise provided in these Bylaws or by law.</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">6</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">Any action required or permitted to be taken at any meeting of the Board of Directors, or of any committee thereof, may be taken without a meeting
        if all members of the Board of Directors or committee, as the case may be, consent thereto in writing or by electronic transmission, and the writing or writings or electronic transmission or transmissions are filed with the minutes of proceedings
        of the Board of Directors or committee. Such filings shall be in paper form if the minutes are maintained in paper form and shall be in electronic form if the minutes are maintained in electronic form.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z41e93273689045d0935a0f528244ca36" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">3.10</td>
            <td style="vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Compensation of Directors</u>.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">The Board of Directors shall have the authority to fix the compensation of the directors. The directors may be paid their expenses, if any, of
        attendance at each meeting of the Board of Directors, and may be paid a fixed sum for attendance at each meeting of the Board of Directors, or paid a stated salary or paid other compensation as director. No such compensation shall preclude any
        director from serving the Corporation in any other capacity and receiving compensation therefore. Members of special or standing committees may be allowed compensation for attending committee meetings.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z4f306d8574974709993bb5eaca7f22df" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">3.11</td>
            <td style="vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Approval of Loans to Officers</u>.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">Subject to applicable law, including Section&#160; 13(k) of the Exchange Act, the Corporation may lend money to, or guarantee any obligation of, or
        otherwise assist any officer or other employee of the Corporation or of its subsidiary, including any officer or employee who is a director of the Corporation or of its subsidiary, whenever, in the judgment of the directors, such loan, guaranty or
        assistance may reasonably be expected to benefit the Corporation. The loan, guaranty or other assistance may be with or without interest and may be unsecured, or secured in such manner as the Board of Directors shall approve, including, without
        limitation, a pledge of shares of stock of the Corporation. Nothing in this section shall be deemed to deny, limit or restrict the powers of guaranty or warranty of the Corporation at common law or under any statute.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z317dca8b9e8646f784ce9b4ffd665d4c" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">3.12</td>
            <td style="vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Removal of Directors</u>.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">Unless otherwise restricted by statute, the Certificate of Incorporation or these Bylaws, any director or the entire Board of Directors may be
        removed, with or without cause, by the holders of a majority of the shares then entitled to vote at an election of directors.</div>
      <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';"> </font><font style="font-size: 10pt;"><br>
        </font></div>
      <table cellspacing="0" cellpadding="0" id="z9240f75ea5c746a7b6933c98a6ceeba5" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">3.13</td>
            <td style="vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Chairman of the Board of Directors</u></font><font style="font-size: 10pt;">.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">The Corporation may have, at the discretion of the Board of Directors, a Chairman of the Board of Directors who shall not be considered by virtue of
        holding such position an officer of the Corporation.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">COMMITTEES</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zae6232f5df3b422796e3a86af965d985" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">4.1</td>
            <td style="vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Committees of Directors</u>.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">The Board of Directors may from time to time designate committees of the Board of Directors, with such lawfully delegable powers and
        duties as it thereby confers, to serve at the pleasure of the Board of Directors and shall, for those committees and any others provided for herein, elect a director or directors to serve as the member or members, designating, if it desires, other
        directors as alternate members who may replace any absent members at any meeting of the committee. In the absence of any member of any committee and any alternate member in his or her place, the member or members of the committee present at the
        meeting, whether or not he or she or they constitute a quorum, may by unanimous vote appoint another member of the Board of Directors to act at the meeting in the place of the absent member. Any Board committee may create one or more subcommittees,
        each subcommittee to consist of one or more members of such committee, and delegate to the subcommittee any or all of the powers of the committee.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z64ba2315cc8b4b12b94a9b45bff9f964" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">4.2</td>
            <td style="vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Committee Minutes</u>.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">Each committee shall keep regular minutes of its meetings and maintain them in the Corporation&#8217;s official minute book.</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">7</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="zfefcae0f8551462d9ade6a6a0a4e2bf8" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">4.3</td>
            <td style="vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Conduct of Business</u>.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">Each committee may determine the procedural rules for meeting and conducting its business and shall act in accordance therewith, except as otherwise
        provided herein or required by law. Adequate provision shall be made for notice to members of all meetings; one-half of the members shall constitute a quorum; and all matters shall be determined by a majority vote of the members present. Action may
        be taken by any committee without a meeting if all members thereof consent thereto in writing or by electronic transmission, and the writing or writings or electronic transmission or transmissions are filed with the minutes of the proceedings of
        such committee. Such filing shall be in paper form if the minutes are maintained in paper form and shall be in electronic form if the minutes are maintained in electronic form.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">The Board of Directors may adopt rules for the governance of any committee not inconsistent with these Bylaws.</div>
      <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';"> </font><font style="font-size: 10pt;"><br>
        </font></div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">OFFICERS</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z60fc6d44d51b443d9e94498d3acdab76" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">5.1</td>
            <td style="vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Officers</u>.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">The officers of the Corporation shall be a chief executive officer, a president, and a secretary. The Corporation may also have, at the discretion
        of the Board of Directors, one or more vice presidents, one or more assistant secretaries, a treasurer and one or more assistant treasurers, and any such other officers as may be appointed in accordance with these Bylaws. Any number of offices may
        be held by the same person.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z7f905db45f0d49b29c330dc0c9e62150" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">5.2</td>
            <td style="vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Appointment of Officers</u>.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">The officers of the Corporation, except such officers as may be appointed in accordance with the provisions of Sections 5.3 or 5.5 of these Bylaws,
        shall be appointed by the Board of Directors.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="ze1fb4864cf6040699e42fd33f90306df" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">5.3</td>
            <td style="vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Subordinate Officers</u>.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">The Board of Directors may appoint, or empower the chief executive officer or the president to appoint, such other officers and agents as the
        business of the Corporation may require, each of whom shall hold office for such period, have such authority, and perform such duties as are provided in these Bylaws or as the Board of Directors or such other officer may from time to time
        determine. The Board of Directors may empower the chief executive officer or the president to define the authority and duties of such subordinate officers.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z5e05e1bb33e74364be77a68808273ac5" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">5.4</td>
            <td style="vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Removal and Resignation of Officers</u>.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">Subject to the rights, if any, of an officer under any contract of employment, any officer may be removed, either with or without cause, by an
        affirmative vote of the majority of the Board of Directors at any regular or special meeting of the Board of Directors or, except in the case of an officer chosen by the Board of Directors, by any officer upon whom such power of removal may be
        conferred by the Board of Directors.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">Any officer may resign at any time by giving written notice to the secretary of the Corporation. Any resignation shall take effect at the date of
        the receipt of that notice or at any later time specified in that notice; and, unless otherwise specified in that notice, the acceptance of the resignation shall not be necessary to make it effective. Any resignation is without prejudice to the
        rights, if any, of the Corporation under any contract to which the officer is a party.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z16f5506f5d9e487dbe9ff5d678a4e00c" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">5.5</td>
            <td style="vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Vacancies in Offices</u>.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">Any vacancy occurring in any office of the Corporation shall be filled in the manner prescribed in these Bylaws for regular appointments to that
        office.</div>
      <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';"> </font><font style="font-size: 10pt;"><br>
        </font></div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">8</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z24c1cc49cafc476e806b895cd8eefc93" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">5.6</td>
            <td style="vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Chief Executive Officer</u>.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">Subject to such supervisory powers, if any, as may be given by the Board of Directors to the chairman of the board, if any, the chief executive
        officer of the Corporation, if such an officer is appointed, shall, subject to the control of the Board of Directors, have general supervision, direction, and control of the business and the officers of the Corporation. He or she shall preside at
        all meetings of the stockholders and, in the absence or nonexistence of a chairman of the board, at all meetings of the Board of Directors, shall have the general powers and duties of management usually vested in the office of chief executive
        officer of a Corporation and shall have such other powers and duties as may be prescribed by the Board of Directors or these Bylaws.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z514704595a3b46c28f1fbc52a2bf5330" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">5.7</td>
            <td style="vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>President</u>.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">Subject to such supervisory powers, if any, as may be given by the Board of Directors to the chairman of the board, if there is one, or the chief
        executive officer, if such an officer is appointed, the president shall be the principal executive officer of the company and shall, subject to the control of the Board of Directors, have general supervision, direction, and control of the business
        and other officers of the Corporation. He or she shall have the general powers and duties of management usually vested in the office of president of a Corporation and such other powers and duties as may be prescribed by the Board of Directors or
        these Bylaws.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z911689922f6e4e0fa08c24e83a17179a" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">5.8</td>
            <td style="vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Vice Presidents</u>.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">In the absence or disability of the chief executive officer and president, the vice presidents, if any, in order of their rank as fixed by the Board
        of Directors or, if not ranked, a vice president designated by the Board of Directors, shall perform all the duties of the president and when so acting shall have all the powers of, and be subject to all the restrictions upon, the president. The
        vice presidents shall have such other powers and perform such other duties as from time to time may be prescribed for them respectively (in order of priority) by the Board of Directors, the chief executive officer, or the president.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z2074dcccd6da43f09616b49e7a0396e8" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">5.9</td>
            <td style="vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Secretary</u>.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">The secretary shall keep or cause to be kept, at the principal executive office of the Corporation or such other place as the Board of Directors may
        direct, a book of minutes of all meetings and actions of directors, committees of directors, and stockholders. The minutes shall show the time and place of each meeting, the names of those present at directors&#8217; meetings or committee meetings, the
        number of shares present or represented at stockholders&#8217; meetings, and the proceedings thereof.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">The secretary shall keep, or cause to be kept, at the principal executive office of the Corporation or at the office of the Corporation&#8217;s transfer
        agent or registrar, as determined by resolution of the Board of Directors, a share register, or a duplicate share register, showing the names of all stockholders and their addresses, the number and classes of shares held by each, the number and
        date of certificates evidencing such shares, and the number and date of cancellation of every certificate surrendered for cancellation.</div>
      <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';"> </font><font style="font-size: 10pt;"><br>
        </font></div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">The secretary shall give, or cause to be given, notice of all meetings of the stockholders and of the Board of Directors required to be given by law
        or by these Bylaws. He or she shall keep the seal of the Corporation, if one be adopted, in safe custody and shall have such other powers and perform such other duties as may be prescribed by the Board of Directors or by these Bylaws.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z8715091a6bd04878841a64649c4f7aa7" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">5.10</td>
            <td style="vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Principal Financial Officer</u>.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">The Board of Directors shall designate an officer appointed pursuant to Section&#160; 5.1 of the Bylaws to serve as the principal financial officer of
        the Company. The principal financial officer shall keep and maintain, or cause to be kept and maintained, adequate and correct books and records of accounts of the properties and business transactions of the Corporation, including accounts of its
        assets, liabilities, receipts, disbursements, gains, losses, capital retained earnings, and shares.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">The principal financial officer shall deposit all moneys and other valuables in the name and to the credit of the Corporation with such depositories
        as may be designated by the Board of Directors. He or she shall disburse the funds of the Corporation as may be ordered by the Board of Directors, shall render to the president, the chief executive officer, or the directors, upon request, an
        account of all his or her transactions as principal financial officer and of the financial condition of the Corporation, and shall have other powers and perform such other duties as may be prescribed by the Board of Directors or the Bylaws.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">9</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z84bd953957264b4eb74d1ae24ec61996" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">5.11</td>
            <td style="vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Action with Respect to Securities of Other Corporations</u>.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">Unless otherwise directed by the Board of Directors, the chief executive officer, the president or any officer of the Corporation authorized by the
        chief executive officer or the president is authorized to vote and otherwise act on behalf of the Corporation, in person or by proxy, at any meeting of stockholders of or with respect to any action of stockholders of any other corporation in which
        the Corporation may hold securities and otherwise to exercise any and all rights and powers which the Corporation may possess by reason of its ownership of securities in such other corporation.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zc89a4387e5ad487db1057db6a5d88882" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">5.12</td>
            <td style="vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Delegation of Authority</u>.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">Notwithstanding any other provision in these Bylaws, the Board of Directors may from time to time delegate the powers or duties of any officer to
        any other officers or agents.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">INDEMNIFICATION OF DIRECTORS, OFFICERS,</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">EMPLOYEES,</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">AND OTHER AGENTS</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z40e439f87f8b449caca64ff1d690f48c" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">6.1</td>
            <td style="vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Indemnification of Directors and Officers</u>.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">Each person who was or is made a party to or is threatened to be made a party to, witness or other participant in any action, suit or proceeding,
        whether civil, criminal, administrative or investigative (a &#8220;Proceeding&#8221;), by reason of the fact that he or she is or was a director or officer of the Corporation (an &#8220;Indemnities&#8221;), whether the basis of the Proceeding is alleged action in an
        official capacity as a director or officer or in any other capacity while serving as a director or officer, shall be indemnified and held harmless by the Corporation to the fullest extent authorized by the DGCL, as the same exists or may hereafter
        be amended (but, in the case of any such amendment, only to the extent that such amendment permits the Corporation to provide broader indemnification rights than such law permitted the Corporation to provide before such amendment), against all
        expense, liability and loss (including attorneys&#8217; fees, judgments, fines, ERISA excise taxes or penalties and amounts paid in settlement) reasonably incurred or suffered by Indemnitee in connection therewith; provided, however, the Corporation
        shall not indemnify any such Indemnitee in connection with a Proceeding (or part thereof) (i)&#160; initiated by such Indemnitee against the Corporation or any director or officer of the Corporation unless the Corporation has joined in or consented to
        the initiation of such Proceeding or (ii)&#160; made on account of Indemnitee&#8217;s conduct which constitutes a breach of Indemnitee&#8217;s duty of loyalty to the Corporation or its stockholders, or is an act or omission not in good faith which involves
        intentional misconduct or a knowing violation of the law. For purposes of this Section&#160; 6.1, a &#8220;director&#8221; or &#8220;officer&#8221; of the Corporation includes any person who (i)&#160; is or was a director or officer of the Corporation , (ii)&#160; is or was serving at
        the request of the Corporation as a director or officer of another corporation, partnership, joint venture, trust or other enterprise, or (iii)&#160; was a director or officer of a corporation that was a predecessor corporation of the Corporation or of
        another enterprise at the request of such predecessor corporation.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z435eb4cc8c534d6085da7be2fd54c3bd" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">6.2</td>
            <td style="vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Indemnification of Others</u>.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">The Corporation shall have the power, to the maximum extent and in the manner permitted by the DGCL, as the same exists or may hereafter be amended
        (but, in the case of any such amendment, only to the extent that such amendment permits the Corporation to provide broader indemnification rights than such law permitted the Corporation to provide before such amendment), to indemnify each of its
        employees and agents against all expense, liability and loss (including attorneys&#8217; fees, judgments, fines, ERISA excise taxes or penalties and amounts paid in settlement) reasonably incurred or suffered by such employees and agents in connection
        therewith; provided, however, provided, however, the Corporation shall not indemnify any such employee or agent in connection with a Proceeding (or part thereof) (i)&#160; initiated by such employee or agent against the Corporation or any director or
        officer of the Corporation unless the Corporation has joined in or consented to the initiation of such Proceeding or (ii)&#160; made on account of such employee&#8217;s or agent&#8217;s conduct which constitutes a breach of such employee&#8217;s or agent&#8217;s duty of
        loyalty to the Corporation or its stockholders, or is an act or omission not in good faith which involves intentional misconduct or a knowing violation of the law. For purposes of this Section&#160; 6.2, an &#8220;employee&#8221; or &#8220;agent&#8221; of the Corporation
        includes any person other than a director or officer (i)&#160; who is or was an employee or agent of the Corporation, (ii)&#160; who is or was serving at the request of the Corporation as an employee or agent of another corporation, partnership, joint
        venture, trust or other enterprise, or (iii)&#160; who was an employee or agent of a corporation which was a predecessor corporation of the Corporation or of another enterprise at the request of such predecessor corporation.</div>
      <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';"> </font><font style="font-size: 10pt;"><br>
        </font></div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">10</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="zb88dc8a41f95423c8b093b416d783ec2" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">6.3</td>
            <td style="vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Payment of Expenses in Advance</u>.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">Expenses incurred in defending any Proceeding for which indemnification is required pursuant to Section&#160; 6.1 shall be, or for which indemnification
        is permitted pursuant to Section&#160; 6.2 following authorization thereof by the Board of Directors may be, paid by the Corporation in advance of the final disposition of such Proceeding upon receipt of an undertaking, by or on behalf of the
        indemnified party to repay such amount if it shall ultimately be determined, by final judicial decision from which there is no further right to appeal, that the indemnified party is not entitled to be indemnified as authorized in this Article VI.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z2bd2c4a68c564f688064a16d8c52e9d6" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">6.4</td>
            <td style="vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Indemnity Not Exclusive</u>.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">The indemnification provided by this Article VI shall not be deemed exclusive of any other rights to which those seeking indemnification may been
        entitled under any Bylaw, agreement, vote of stockholders or disinterested directors or otherwise, both as to action in an official capacity and as to action in another capacity while holding such office.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zaeb21e664b1144208b147b8f84502cc6" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">6.5</td>
            <td style="vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Insurance</u>.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">The Corporation may purchase and maintain insurance on behalf of any person who is or was a director, officer, employee or agent of the Corporation,
        or is or was serving at the request of the Corporation as a director, officer, employee or agent of another Corporation, partnership, joint venture, trust or other enterprise against any liability asserted against him or her and incurred by him or
        her in any such capacity, or arising out of his or her status as such, whether or not the Corporation would have the power to indemnify him or her against such liability under the provisions of the DGCL.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">RECORDS AND REPORTS</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zed18b425a5ec4797b3ee9b59b84578a1" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">7.1</td>
            <td style="vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Maintenance and Inspection of Records</u>.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">The Corporation shall, either at its principal executive offices or at such place or places as designated by the Board of Directors, keep a record
        of its stockholders listing their names and addresses and the number and class of shares held by each stockholder, a copy of these Bylaws as amended to date, accounting books and other records.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">Any stockholder of record, in person or by attorney or other agent, shall, upon written demand under oath stating the purpose thereof, have the
        right during the usual hours for business to inspect for any proper purpose the Corporation&#8217;s stock ledger, a list of its stockholders, and its other books and records and to make copies or extracts therefrom. A proper purpose shall mean a purpose
        reasonably related to such person&#8217;s interest as a stockholder. In every instance where an attorney or other agent is the person who seeks the right to inspection, the demand under oath shall be accompanied by a power of attorney or such other
        writing that authorizes the attorney or other agent to so act on behalf of the stockholder. The demand under oath shall be directed to the Corporation at its registered office in Delaware or at its principal place of business.</div>
      <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';"> </font><font style="font-size: 10pt;"><br>
        </font></div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">A complete list of stockholders entitled to vote at any meeting of stockholders, arranged in alphabetical order for each class of stock and showing
        the address of each such stockholder and the number of shares registered in each such stockholder&#8217;s name, shall be open to the examination of any such stockholder for a period of at least ten days before the meeting in the manner provided by law.
        The stock list shall also be open to the examination of any stockholder during the whole time of the meeting as provided by law. This list shall presumptively determine the identity of the stockholders entitled to vote at the meeting and the number
        of shares held by each of them.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z7a735f53ca5546d4810da8fcdb3ff859" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">7.2</td>
            <td style="vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Inspection by Directors</u></font><font style="font-size: 10pt;">.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">Any director shall have the right to examine the Corporation&#8217;s stock ledger, a list of its stockholders, and its other books and records for a
        purpose reasonably related to his or her position as a director.</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">11</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">GENERAL MATTERS</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z8a3192b3177944c9b0e8e03982ea9817" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">8.1</td>
            <td style="vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Checks</u></font><font style="font-size: 10pt;">.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">From time to time, the Board of Directors shall determine by resolution which person or persons may sign or endorse all checks, drafts, other orders
        for payment of money, notes or other evidences of indebtedness that are issued in the name of or payable to the Corporation, and only the persons so authorized shall sign or endorse those instruments.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z955bf2076a194e0cae4b8e388d18a5c4" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">8.2</td>
            <td style="vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Execution of Corporate Contracts and Instruments</u></font><font style="font-size: 10pt;">.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">The Board of Directors, except as otherwise provided in these Bylaws, may authorize any officer or officers, or agent or agents, to enter into any
        contract or execute any instrument in the name of and on behalf of the Corporation; such authority may be general or confined to specific instances. Unless so authorized or ratified by the Board of Directors or within the agency power of an
        officer, no officer, agent or employee shall have any power or authority to bind the Corporation by any contract or engagement or to pledge its credit or to render it liable for any purpose or for any amount.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z3019bd01db4744efb8ea8ab9f17ae8d2" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">8.3</td>
            <td style="vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Stock Certificates</u></font><font style="font-size: 10pt;">.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">The shares of the Corporation shall be represented by certificates provided, however, that the Board of Directors may provide by resolution or
        resolutions that some or all of any or all classes or series of its stock shall be represented by uncertificated shares, and provided, further, that any such resolution shall not apply to shares represented by a certificate until such certificate
        is surrendered to the Corporation. Every holder of stock represented by certificates shall be entitled to have a certificate signed by, or in the name of the Corporation by the chairman or vice-chairman of the Board of Directors, or the president
        or vice-president, and by the treasurer or an assistant treasurer, or the secretary or an assistant secretary of the Corporation. Any or all of the signatures on the certificate may be a facsimile. In case any officer, transfer</div>
      <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';"> </font><font style="font-size: 10pt;"><br>
        </font></div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">agent or registrar who has signed or whose facsimile signature has been placed upon a certificate has ceased to be such officer, transfer agent or registrar before such
        certificate is issued, the certificate may be issued by the Corporation with the same effect as if such person were such officer, transfer agent or registrar at the date of issue.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">No stock certificates will be issued in bearer form.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zd0c558a669524f12b4d4341d6e184c36" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">8.4</td>
            <td style="vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Special Designation on Certificates</u>.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">If the Corporation is authorized to issue more than one class of stock or more than one series of any class, then the powers, the designations, the
        preferences, and the relative, participating, optional or other special rights of each class of stock or series thereof and the qualifications, limitations or restrictions of such preferences and/or rights shall be set forth in full or summarized
        on the face or back of the certificate that the Corporation shall issue to represent such class or series of stock; provided, however, that, except as otherwise provided in Section&#160; 202 of the DGCL, in lieu of the foregoing requirements there may
        be set forth on the face or back of the certificate that the Corporation shall issue to represent such class or series of stock a statement that the Corporation will furnish without charge to each stockholder who so requests the powers, the
        designations, the preferences, and the relative, participating, optional or other special rights of each class of stock or series thereof and the qualifications, limitations or restrictions of such preferences and/or rights.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z6c642ad5627c407bb96731f8288a7d75" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">8.5</td>
            <td style="vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Lost Certificates</u></font><font style="font-size: 10pt;">.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">Except as provided in this Section&#160; 8.5, no new certificates for shares shall be issued to replace a previously issued certificate unless the latter
        is surrendered to the Corporation and canceled at the same time. The Corporation may issue a new certificate of stock in the place of any certificate previously issued by it, alleged to have been lost, stolen, mutilated or destroyed, and the
        Corporation may require the owner of the lost, stolen, mutilated or destroyed certificate, or the owner&#8217;s legal representative, to give the Corporation a bond sufficient to indemnify it against any claim that may be made against it on account of
        the alleged loss, theft, mutilation or destruction of any such certificate or the issuance of such new certificate.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">12</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z873a74ba42f84b1abb9c72a9d8d0d0c4" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">8.6</td>
            <td style="vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Construction; Definitions</u></font><font style="font-size: 10pt;">.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">Unless the context requires otherwise, the general provisions, rules of construction, and definitions in the DGCL shall govern the construction of
        these Bylaws. Without limiting the generality of this provision, the singular number includes the plural, the plural number includes the singular, and the term &#8220;person&#8221; includes both a corporation and a natural person.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zed633cebac6f4522b0988fc931948c17" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">8.7</td>
            <td style="vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Fiscal Year</u></font><font style="font-size: 10pt;">.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">The fiscal year of the Corporation shall be fixed by resolution of the Board of Directors and may be changed by the Board of Directors.</div>
      <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';"> </font><font style="font-size: 10pt;"><br>
        </font></div>
      <table cellspacing="0" cellpadding="0" id="zd8bd7d0df3d647ddb6d545b3826df35c" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">8.8</td>
            <td style="vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Seal</u></font><font style="font-size: 10pt;">.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">The Corporation may adopt a corporate seal, which may be altered at pleasure, and may use the same by causing it or a facsimile thereof, to be
        impressed or affixed or in any other manner reproduced.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z4425fddbbe094d06b4f4101ed3044fbb" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">8.9</td>
            <td style="vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Transfers of Stock</u></font><font style="font-size: 10pt;">.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">Transfers of stock shall be made only upon the transfer books of the Corporation kept at an office of the Corporation or by transfer agents
        designated to transfer shares of the stock of the Corporation.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zde34ca397f35438a88b647b3ec80cc1c" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">8.10</td>
            <td style="vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Registered Stockholders</u></font><font style="font-size: 10pt;">.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">The Corporation shall be entitled to recognize the exclusive right of a person registered on its books as the owner of shares to receive dividends
        and to vote as such owner and shall not be bound to recognize any equitable or other claim to or interest in such share or shares on the part of another person, whether or not it shall have express or other notice thereof, except as otherwise
        provided by the laws of Delaware.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zbc93899ef7fb419f91bed324e1d0f544" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27.05pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">8.11</td>
            <td style="vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Facsimile Sign<font style="font-weight: bold;">a</font>tures</u></font><font style="font-size: 10pt;">.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">In addition to the provisions for use of facsimile signatures elsewhere specifically authorized in these Bylaws, facsimile signatures of any officer
        or officers of the Corporation may be used whenever and as authorized by the Board of Directors or a committee thereof.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" id="z13f880bed1fc4ea0ae901de8886ff87b" class="DSPFListTable">

            <tr style="vertical-align: top;">
              <td style="vertical-align: top; width: 27.05pt;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">8.12.</font></div>
              </td>
              <td style="vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Exclusive Forum</u></font><font style="font-size: 10pt;">.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">Unless the Corporation consents in writing to the selection of an alternative forum, the sole and exclusive forum for (A) any derivative action or
        proceeding brought on behalf of the Corporation, (B) any action asserting a claim of breach of a fiduciary duty owed by any director or officer or stockholder of the Corporation to the Corporation or the Corporation's stockholders, (C) any action
        asserting a claim against the Corporation or any director or officer or stockholder of the Corporation arising pursuant to any provision of the DGCL or this Certificate of Incorporation or these Bylaws, or (D) any action asserting a claim against
        the Corporation or any director or officer or stockholder of the Corporation governed by the internal affairs doctrine, shall be a state court located within the State of Delaware (or, if no state court located within the State of Delaware has
        jurisdiction, the federal district court for the District of Delaware).</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">If any provision of this Section 8.12 is held to be invalid, illegal or unenforceable as applied to any person or entity or circumstance for any
        reason whatsoever, then, to the fullest extent permitted by law, the validity, legality and enforceability of such provision in any other circumstance and of the remaining provisions of this Section 8.12 (including, without limitation, each portion
        of any sentence of this Section 8.12 containing any such provision held to be invalid, illegal or unenforceable that is not itself held to be invalid, illegal or unenforceable) and the application of such provision to other persons or entities or
        circumstances shall not in any way be affected or impaired thereby.</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">13</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">AMENDMENTS</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 48.95pt; font-family: 'Times New Roman'; font-size: 10pt;">The Bylaws of the Corporation may be adopted, amended or repealed, in whole or in part, by the majority vote of the Board of Directors or by the
        stockholders entitled to vote; <font style="font-family: 'Times New Roman';"><u>provided</u></font>, <font style="font-family: 'Times New Roman';"><u>however</u></font>, that no bylaw may be adopted, amended or repealed by the
        stockholders except by the vote or written consent of at least 66 2/3% of the voting power of the Corporation.</div>
      <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';"> </font><font style="font-size: 10pt;"><br>
        </font></div>
      <font style="font-size: 10pt;"><br>
      </font>
      <div style="font-size: 10pt; text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">14</font></div>
      <div style="font-size: 10pt;">
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
  <font style="font-size: 10pt;">
  </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.3
<SEQUENCE>4
<FILENAME>brhc10042808_ex3-3.htm
<DESCRIPTION>EXHIBIT 3.3
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc
         Document created using Broadridge PROfile 22.10.1.5080
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">

  <font style="font-size: 10pt;"> </font>
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> Exhibit 3.3<br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CERTIFICATE OF AMENDMENT </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">OF </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">RESTATED CERTIFICATE OF INCORPORATION </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">OF </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">BROOKLYN IMMUNOTHERAPEUTICS, INC. </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Brooklyn ImmunoTherapeutics, Inc. (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Corporation</font>&#8221;), a
        Delaware corporation, does hereby certify that:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">1.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The certificate of incorporation of the
            Corporation is hereby amended by adding the following paragraph to the end of Article IV thereof:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-right: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;Effective immediately upon the effectiveness of the Certificate of Amendment adding this paragraph to Article IV of this
        Certificate of Incorporation (the &#8220;Effective Time&#8221;), each ten (10) to twenty (20) shares of Common Stock that are issued and outstanding immediately prior to the Effective Time shall be reclassified and combined into one (1) validly issued, fully
        paid and non-assessable share of Common Stock, with the exact ratio within such range to be determined by the Board of Directors prior to the Effective Time and publicly announced by the Corporation, subject to the treatment of fractional share
        interests as described below (the &#8220;Reverse Stock Split&#8221;). The Reverse Stock Split shall occur automatically without any further action by the Corporation or its stockholders and whether or not any certificate representing such shares immediately
        prior to the Effective Time (the &#8220;Old Certificate&#8221;) is surrendered to the Corporation. The Reverse Stock Split shall also apply to any outstanding securities or rights convertible into, or exchangeable or exercisable for, Common Stock. The Reverse
        Stock Split shall be effected on a certificate-by-certificate basis and no fractional shares shall be issued upon the reclassification and combination. In lieu of any fractional shares to which the holder would otherwise be entitled, the
        Corporation shall pay an amount of cash equal to the product of (i) the fractional share to which the holder would otherwise be entitled and (ii) the then fair value of a share as determined in good faith by the Board of Directors. Following the
        Effective Time, each Old Certificate shall thereafter represent that number of shares of Common Stock into which the shares of Common Stock represented by the Old Certificate shall have been reclassified and combined, subject to the elimination of
        fractional share interests as described above, until such time as such Old Certificate has been surrendered to the Corporation.&#8221;</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The amendment set forth in this
            Certificate of Amendment has been duly adopted in accordance with Section 242 of the General Corporation Law of the State of Delaware.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">3.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman';">On October 4, 2022, the Board of
            Directors of the Corporation determined that each twenty (20) shares of the Corporation&#8217;s common stock, par value $0.005 per share (&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Common Stock</font>&#8221;), issued and outstanding
            immediately prior to the Effective Time, shall automatically be reclassified and combined into one (1) validly issued, fully paid and non-assessable share of Common Stock, pursuant to the amendment set forth in this Certificate of Amendment.
            The Corporation publicly announced this ratio on October 11, 2022.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">4.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-family: 'Times New Roman';">This Certificate of Amendment shall be
            effective on October 16, 2022 at 11:59 p.m. Eastern Time.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">[Remainder of Page Intentionally Left Blank]</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%%%-->
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; IN WITNESS WHEREOF, the Corporation has caused this Certificate to be executed and acknowledged on October 11, 2022.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z61cc4adb70bf4299a6ef9bfce3b071c4">

          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="3" style="vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">BROOKLYN IMMUNOTHERAPEUTICS, INC.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;">&#160;</td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;">
              <div style="text-align: left; font-family: 'Times New Roman';">By:</div>
            </td>
            <td style="width: 35%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt; margin-left: 9pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">/s/</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Matthew Angel</font></div>
            </td>
            <td style="width: 12%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Matthew Angel, Interim Chief Executive Officer and President</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="font-size: 10pt; text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;"> <br>
        </font></div>
      <div style="font-size: 10pt; text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">2</font></div>
      <div style="font-size: 10pt;">
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
  <font style="font-size: 10pt;"> </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>btx-20221011.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 22.10.1.5080 Broadridge-->
<xs:schema targetNamespace="http://brooklynitx.com/20221011" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:btx="http://brooklynitx.com/20221011" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="btx-20221011_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="btx-20221011_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://brooklynitx.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2022" schemaLocation="https://xbrl.sec.gov/currency/2022/currency-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2022" schemaLocation="https://xbrl.sec.gov/exch/2022/exch-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2022" schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2022" schemaLocation="https://xbrl.sec.gov/sic/2022/sic-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2022" schemaLocation="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>btx-20221011_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 22.10.1.5080 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract_lbl" xml:lang="en-US" id="dei_CoverAbstract_lbl">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:title="label: CoverAbstract to dei_CoverAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType_lbl" xml:lang="en-US" id="dei_DocumentType_lbl">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType_lbl" xlink:title="label: DocumentType to dei_DocumentType_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications_lbl" xml:lang="en-US" id="dei_WrittenCommunications_lbl">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:title="label: WrittenCommunications to dei_WrittenCommunications_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial_lbl" xml:lang="en-US" id="dei_SolicitingMaterial_lbl">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementTenderOffer_lbl">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer_lbl">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag_lbl" xml:lang="en-US" id="dei_AmendmentFlag_lbl">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:title="label: AmendmentFlag to dei_AmendmentFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalYearFocus_lbl">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus_lbl">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" id="dei_DocumentPeriodEndDate_lbl">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="dei_EntityRegistrantName_lbl">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="dei_EntityCentralIndexKey_lbl">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber_lbl" xml:lang="en-US" id="dei_EntityFileNumber_lbl">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:title="label: EntityFileNumber to dei_EntityFileNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber_lbl">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode_lbl">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="CurrentFiscalYearEndDate" xlink:title="CurrentFiscalYearEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US" id="dei_CurrentFiscalYearEndDate_lbl">Current Fiscal Year End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:title="label: CurrentFiscalYearEndDate to dei_CurrentFiscalYearEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany_lbl">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine1_lbl">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine2_lbl">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine3_lbl">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" id="dei_EntityAddressCityOrTown_lbl">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" id="dei_EntityAddressStateOrProvince_lbl">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry_lbl" xml:lang="en-US" id="dei_EntityAddressCountry_lbl">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" id="dei_EntityAddressPostalZipCode_lbl">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode_lbl" xml:lang="en-US" id="dei_CityAreaCode_lbl">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:title="label: CityAreaCode to dei_CityAreaCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber_lbl" xml:lang="en-US" id="dei_LocalPhoneNumber_lbl">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle_lbl" xml:lang="en-US" id="dei_Security12bTitle_lbl">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:title="label: Security12bTitle to dei_Security12bTitle_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US" id="dei_NoTradingSymbolFlag_lbl">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol_lbl" xml:lang="en-US" id="dei_TradingSymbol_lbl">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:title="label: TradingSymbol to dei_TradingSymbol_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName_lbl" xml:lang="en-US" id="dei_SecurityExchangeName_lbl">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName_lbl" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>btx-20221011_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 22.10.1.5080 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://brooklynitx.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="btx-20221011.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="CurrentFiscalYearEndDate" xlink:title="CurrentFiscalYearEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CurrentFiscalYearEndDate" xlink:title="presentation: CoverAbstract to CurrentFiscalYearEndDate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFileNumber" xlink:title="presentation: CoverAbstract to EntityFileNumber" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: CoverAbstract to EntityIncorporationStateCountryCode" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: CoverAbstract to EntityTaxIdentificationNumber" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine1" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine2" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine3" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: CoverAbstract to EntityAddressCityOrTown" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCountry" xlink:title="presentation: CoverAbstract to EntityAddressCountry" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: CoverAbstract to EntityAddressPostalZipCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CityAreaCode" xlink:title="presentation: CoverAbstract to CityAreaCode" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="LocalPhoneNumber" xlink:title="presentation: CoverAbstract to LocalPhoneNumber" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="Security12bTitle" xlink:title="presentation: CoverAbstract to Security12bTitle" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="TradingSymbol" xlink:title="presentation: CoverAbstract to TradingSymbol" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: CoverAbstract to NoTradingSymbolFlag" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SecurityExchangeName" xlink:title="presentation: CoverAbstract to SecurityExchangeName" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="WrittenCommunications" xlink:title="presentation: CoverAbstract to WrittenCommunications" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SolicitingMaterial" xlink:title="presentation: CoverAbstract to SolicitingMaterial" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementTenderOffer" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementIssuerTenderOffer" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139651625537312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Oct. 11, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Oct. 11,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-11460<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Brooklyn ImmunoTherapeutics, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000748592<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">31-1103425<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">10355 Science Center Drive<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92121<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">212<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">582-1199<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.005 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BTX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>brhc10042808_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="btx-20221011.xsd" xlink:type="simple"/>
    <context id="c20221011to20221011">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <startDate>2022-10-11</startDate>
            <endDate>2022-10-11</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20221011to20221011"
      id="Fact_f4c74f3a50114068b8fc6df280953aa1">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate
      contextRef="c20221011to20221011"
      id="Fact_0c42e9fbb1a94d67bd4fe2061ffa4b4a">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityCentralIndexKey
      contextRef="c20221011to20221011"
      id="Fact_98d859a654154548904d5bc925c4d2d2">0000748592</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="c20221011to20221011"
      id="Fact_74af326254b54e3ea3b1f90a4a82d9c1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20221011to20221011"
      id="Fact_d4e40098caee47eeac575a40fc534cd3">2022-10-11</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20221011to20221011"
      id="Fact_d6ca176d43b54f5ca44ffa3fb23a053b">Brooklyn ImmunoTherapeutics, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20221011to20221011"
      id="Fact_02b28958ec194c53a4cddd03a9ca151b">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20221011to20221011"
      id="Fact_f0d9dd2225764eaaa6ba9952f0e3440a">001-11460</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20221011to20221011"
      id="Fact_4c46da281ba54cbcbfeb92ad2fe81f0f">31-1103425</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20221011to20221011"
      id="Fact_5b11d15cab4a4b519cf8e6946af70c20">10355 Science Center Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="c20221011to20221011"
      id="Fact_cbc19756eeee43c797358ae8a49fb202">Suite 150</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="c20221011to20221011"
      id="Fact_34112a7a0efb47138fd2329af1e48d97">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="c20221011to20221011"
      id="Fact_527b3f309abe452db9d915551f843097">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="c20221011to20221011"
      id="Fact_255037ece31343c5a7beac9c081249c6">92121</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20221011to20221011"
      id="Fact_0ad11d08743740f9949d326f407762e5">212</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20221011to20221011"
      id="Fact_95ae2803545845cca7bc14c11e9213a4">582-1199</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20221011to20221011"
      id="Fact_fc126e0906934d6cb9a6593b2ed042b0">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20221011to20221011"
      id="Fact_546bff35ea714b3daff1c3783d3da515">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20221011to20221011"
      id="Fact_61afcada52944ec5b08b921acb8176bc">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20221011to20221011"
      id="Fact_19e91ba63e804c2db51df991aa0d9cd5">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20221011to20221011"
      id="Fact_146d02dd6ad44a9ea067d3464fc340b0">Common Stock, par value $0.005 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20221011to20221011"
      id="Fact_0a298397c4b24d1dbe4048c10c25863e">BTX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20221011to20221011"
      id="Fact_6c4d5357ecc64860a44eff1dbe9d85e8">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20221011to20221011"
      id="Fact_dbe7ed8b6c534e27948be6d820d5f6ba">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04    " #(0TM5'#AEZC\!   \ @
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M>::W=Y-[2:AU[D&P]_ :C1W-CQ^W_ %02P,$%     @ R$-+520>FZ*M
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M8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " #(0TM5E_1'3>T    K @  $0
M            @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " #(
M0TM5F5R<(Q &  "<)P  $P              @ '+ 0  >&PO=&AE;64O=&AE
M;64Q+GAM;%!+ 0(4 Q0    ( ,A#2U6JGG@HD@0  .81   8
M  " @0P(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " #(
M0TM5GZ ;\+$"  #B#   #0              @ '4#   >&PO<W1Y;&5S+GAM
M;%!+ 0(4 Q0    ( ,A#2U67BKL<P    !,"   +              "  ; /
M  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( ,A#2U4<.&7J/P$  #P"   /
M          "  9D0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " #(0TM5
M)!Z;HJT   #X 0  &@              @ $%$@  >&PO7W)E;',O=V]R:V)O
M;VLN>&UL+G)E;'-02P$"% ,4    " #(0TM599!YDAD!  #/ P  $P
M        @ 'J$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"
(   T%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="brhc10042808_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="brhc10042808_8k.htm">brhc10042808_8k.htm</File>
    <File>brhc10042808_ex3-1.htm</File>
    <File>brhc10042808_ex3-2.htm</File>
    <File>brhc10042808_ex3-3.htm</File>
    <File>btx-20221011.xsd</File>
    <File>btx-20221011_lab.xml</File>
    <File>btx-20221011_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "brhc10042808_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "brhc10042808_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "btx-20221011_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "btx-20221011_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "btx-20221011.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/exch/2022/exch-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd",
      "https://xbrl.sec.gov/sic/2022/sic-2022.xsd",
      "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"
     ]
    }
   },
   "elementCount": 30,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 24,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "btx",
   "nsuri": "http://brooklynitx.com/20221011",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10042808_8k.htm",
      "contextRef": "c20221011to20221011",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000100 - Document - Document and Entity Information",
     "role": "http://brooklynitx.com/role/DocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10042808_8k.htm",
      "contextRef": "c20221011to20221011",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001140361-22-036744-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-22-036744-xbrl.zip
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MU[WND L&GE=RRR6W5"T?EC,$SM1DKODH,. >'56A"%[9\[+[B\58D[U$E?I
MT3D,1KX22I\X.\/HXT!HYH*=.$,E37%(QES,:_"AS\<LA Z;04^-B?QP#-']
MD/]@-7#+$W,,AMV:(A%\)&L@V!!G(LHUV"E'GV,GYF\WYIADB#@-E,].QDLI
M_YZ:-] @51@0BKN2@0,1MQ,'C6Z87D@>,&N&&NQ/;N_)  /B?QMI-96TN'PK
MJT!,\AC&1(^X+%I]:D"F1BVF=,PDGALH31G2DDJR1,^<^/%%*F"6441FF:@W
M,4NLW?UJJ6)G-W9+-#%+3#)0@J)\K=N #[B!2LFM[ZV3\KYOWN^X!^7C]3M6
M&?!9Y#UK]?KMB_99L]^"[@4TKUJ=<_SOX\4;2--KW?11DG-8$JO=.>OVKKN]
M9K_=[;R-:*>];O>OR[\[T+ZZ^M+I]O]L]9K7K2_]]ME-P<I7VL3=]8&^6_DH
M7>*PCV:XI*A8#2K5TE'U'IRKVT 9U=-*?1-S">WQ>"I5/V":3!@F5#_.IR7X
M: (&[W<./0^!>B_3/,0L9\V$O]U> VY01=]"4>F)TL3F\"131=S<XT^%=[_=
MI6,"YTR0&=$,,]!B1P&H0KXH-AO,T?/:\.$<3$!,[?4=XZ[T"E+_68)^R&E.
MPRTE=GD@T<?)9+OO33SK-! FB:VYCT<KJ&'FV,0/EQD7X5VP&,KX&?C"902/
M:(J',PXI$\S8([J)E'T\E]MVGV:XG^,6$P*:F6MF<)>D.!=:$7"]I3Y40JB9
MO<*U@K-INK>6&B_]>9GL'.-ANR-^ :"#A&T4;-;($LV3VB]KTFQ09NR:!HZU
M;PMSH"20C>@HH),U;QL=R:E<+1VNSF1/CAGO5XR9;#J+4IK%?E2BALR@3MH$
M%KTF0/>=Y<(+FHNE 0EAP)@$.A48"%1-;&V+VXB/"*%8%3.8<:1TP_P(*]Z^
MET+H#R81#2(7BI=DEMZ^,0FW--.67C-V7B675GY!7-SS=AXE=Z['&ET(=#ZP
MX= Z]SLNEM#UC1HP#>[G0MRA$&Q8O%K9!5(:EZ!%0IL)P+)^)7]N6X YC7]Z
M;$PL!K2%X37!)JN-M*1%*NH^ATN$ IP*(K_]^]*RP -ISQ<D#$^<T][UA17T
M%+O,;TW\6G1->(01;4L?$RR@;-0DQ6HR@[>-&B^XWOE^+9,%@PG.% =VJDB&
MQG9+1,S(/,R16=?I)31B*:+6#LJVO9MQ:@(K3GDW[<**R1QV=&DGZ&W8"69M
MX2P#+W^%;7_2F%N-.],Q@KO',$/NXGC7V]W=Q;[[*?&Y[AO+>?C:[G=:-S?P
M%>O\5O>B<*]RL>G7)]/HD<1RY!H5!><M\Z<V)]LB!2TBU4PP.L*);+"Z<;"6
MGA!]A@R$K<.$""?$Q]+GQ"D[T?6$4)I>QRZ,AIR>.#_H@.TSXKK>4:6R?[A?
M/J+^L%RI'/B4><0GE>T?5ZQ"#N) D$F(:]+13QYKZ-'@8[D ]N]3#L,Y-!O=
MR"?(NJ&IS(D(52O!=^L9GXB4%8;>JC!/36OH>K*/(V750$_($Z?B+-%Z8MVX
M<1N:!M:24CB1-]Y;&#,A6WDFJ@NC>\YF[EI']H6-!$EP+A*_3:4O8[DUK#:#
M9KYB/WA4E74ZKST*CRNU6VO))*5DE(%0"4[7YXV7T2]G9^_I5>GJQR)[X=YC
M2M6'G9$BZ^FT5@MZ10P>DC-HRA$3*RO+#;SO?E[G_8W"YO]$ER7[\@&?PT A
MJMDU'\-9P-D06E%!9+N5[A K):Q^;&5TK5G(;;.WS<EU5SI&1="S/L=XKGVK
MWGZLRA2/2S2']QY02Z7'1.2#,IES&MX6+5ZF]=CBW="F'<'SO1O*ZG@WSHP>
M^WZLOF=?X$6#Y#7E?U!+ P04    " #(0TM5S%!+@\M)  "/]P$ %@   &)R
M:&,Q,# T,C@P.%]E>#,M,BYH=&WM?6ESVU;6YO>IFO^ 25?>UZZBW5Q $HS3
MJ5)LN=LUB9VQU9UZ/UX %Q)B$F!CD:S^]7.6NP(@)3FR8H5,=2<4"=S]GO4Y
MYWQ_T6S6/_SO_Q4$WU](D=(G^-SDS5K^\/U?^;_JR__S[%GP4Y[(HI9IT)3?
M!3]6I4BK/#V7P>N\$$62BW7PH5RW35X6]2AX4R3\*OWSJDS:C2R:(*FD:*")
MMLZ+<[>17]Z_R_*U#*;3YY/Q\\GS^3@:.PV\++?757Y^T023U6H>/ NFX^G4
M??_9,Y[)7]54OH_+]#J(SY-R759_^^8O&?WS35 WUVOYMV^RLFB>96*3KZ^_
M"_[[+-_(.G@KKX+WY484__TBH-_K_#_RNV RWC8O@D9^:IZ)=7Y>?!>L90;?
M4,O?!7\9TS\OON'^\46O$Z<1]<A?\7O^F.:7^F&W YJI>AQWIPJ*LKX0*3RF
M/IB)7$A\]KL@W'XR0ZK.XR?C48#_>_HBB$7R\;PJVR)]-OC[1E3G>?$,)_5=
M(-JF-%]5W#1_%Y=5*N'EC4SS=@,#*J0=(<SCA_[4K]38XG*=]I?TFQ]./UWD
M<=X$L^?3[^/J![W=:H&^_RNV:CL86BC:B6_LF\YC_>[\/FSCNYN'\][(2@W]
M+J>E/_UO?OCQ?WXZ^?7#[H[[ _ZOOTP6XQ=_P%#?O7X4PSP].WW_]B0X^\?I
M^Y-?3O]Y]N;EA^#-VY?/'\7@GX@Z$$ 34Z"&HDB#2M8-D<;F B[K^47P+FG*
M6%;!9#DB:O?T7J:5K$5=_^V;']__\OH7<2Y_!'K\\03^90A*LI:BPE$V%X80
M-.563T5] S\WY<:C:S=T8CK8PC?/8OSJF<@:)"EB?26N:Z^9&Z@>CX*H7C!&
MRG>5I\T%#F?\K295S]1WXQ>!)I)3ATAJNCU '\U/[EI\\T-G-1_^R'PX??GN
M[:O@Y.?3MZ].X;_P^?WIA[.3L]-7C^+('RG@D0*Z@\\RF33YI>R1ND<Q_)?O
MWO_R[CU<ON#=Z]=O7I[^_H/=B!@DX$2NU_56)" @_^V;\3?T]U:DJ?X[3__V
MS7_B:#E;A@G0Q$D<3N?+.(G#R21+5S)>C,,)4$I%@U]]^.7U3WG=G&';GR_^
M>O3UEK(P_^/1]*;R:#Q^D^HQJ2ZFR^?C.79Y*:LF3\1:]P1,Z)YV;O)\ NI-
MNGLH@UWW9STLWWMM=@_!34/OC/3[]H?W\ARV3U8@&;S+,E#!X'*W'5ZD.5)G
M3O!%-; 3\#4>AB]POWA9Z)L<!)L"]9+H^6IN-N(.._?-#V<7$J0B,_N29@__
M 0E)@D)8;<M*H+89@&RP7@>Q#/*"?\N;:WSNUWR]@5O3E,4(GF\+_A8[?2EJ
M4&Y'P0<4N?#+5W(MKD0EGP?8:P&"F>[(CL"N)$@PH.H,C$2  M0F%\&Z3/B+
MO#:_R^ $7V/=^/=3Z#L0BTDLXG">S2:+118"K5AEJ_E,K(0,Q]%D%1Z)Q7YB
M,7T\Q.(=',A*T8GZJR<4=R<)W,=#_IOHP8^EJ%(B$WD%(DM9U: '7>-M%\5U
MT,#  ]3>XG5>7P0E[0%3JUH_LUT+I%T5?ZB#*WA&]L@'4(M_M[!$64Y6MB M
M@Q@M9;*N'X=(]_/IZ=F;MW__ ")1\.'LW<O_^X]W/[TZ??^@HM$\G,HX%>-P
M'(IP$L^C6&1RD639*DIGR^GD2.WV;.#T,8E&)T4!MR7X6<H&3L#73^_N4S 2
M//<-SUW+(G53)A\O8($DD*B^?#*"QBKZ<MO"ES4).7*-6AA0'_B<&OJ&)BE\
MF,09)FF:% 6"R1](3%F[7E_#$=](NYJQA/= %FM&5C"[D&N@GP6WEJ(LA.UK
M:8D(J&H4'DYE#8M&MK"L*C?\,U!#^F]\3>/O4^3G>RCU""7#O*F#N@0JDN9U
M4DE>CU0"\0,A$6DQ# >;UDNJ1D-#Q_=@HM#Y1HJ"EK:2F[)QI@V+L&F+/%$+
M#=/98LL-3@/>^\"+K)C*=#+1VZ,ES^#OLI 5;*G+$'X25\$3?.J__A)-I^,7
MK_[^\B?Z.'GQ](MQA/L]K"?( &]Q7$=P/F")Z4"8DV8.4%(6:9O@6@K][86X
MA.,@91%LJQ+6&O>'+*>-/H+.;L+I %[J;->N=WIC'=G1;-H:G_LN>'+R5&UD
MO94)LVNE>Q1EH[04/=<G<(M0!*C;[78MR0N&UTDVY=/@/+^$\</QP&?X^/$5
M5/=Q^*B/@B<_Z@'0U;S*X2K?8A6\GNQ:W*I+>._)R\_N5;A[_3QX73KDI,&=
MN?V&])H;=<\2;Q2=#UY@I!S0LMH;6GV87%[8);BJ<FH;R0PT!K<5-DA4UP-$
M5!TEU2CLQ42ORE7>7* ='\Y$HUN:CL?+FT\_WNG)\D7M3\Q\JP:NSA\0K35,
MJV(9$59R(_*U\2(D$GY+]6G:5GF1Y%OH7'Z224O6-BV:#NBO16F79 T4&)F%
MX(--5)N()$BI!>P<:--/5F,]=Q )9)&*"IZ[KO$RB/12%%9?AR7 ,=>XIJE2
MNM7Z+ ;6QZ<,.+,GTUW+[+]==U^'%3O/H7=H&(8%_46&N5U+ ;_3>2!7!/1D
MY_\';\3@^O?(C?..&23<I$] ;M"T0=2F @XOV&_O+PRT 72U4'>?EI6'*B_S
MLJWM4N ZV2-ZPV9=7>2:R1OR#>L&; 7O.DZG?WIP[9AJP,\E<..+MDAI7:\D
MFFV>3*:?==+45_K $7/1T_-GU5FT%_C%99[*=!1<E%?RDLD,GO[,KHO;=M,7
MRN"BJ+&ESO1F8QZYHF\P=3A&XIK%A/YC=#!W36R+QPS5GWU;1+0[[Y^Q-$]I
M8W#G!LBL.F%^%R-]!>)K?QE<\MLX]-'<E;ITK@N=!_]\)VLECQJ^4/(/_)R:
M\&K<X-FZUJM'.]H]D;Q<$_UH5J[7Y151=]JO:VR93^FV!9T]P0;*%K9IXYCU
MO#/C[&B65S"AC4CE<[L")_NH18^G\+6H98-$" 8IB =*@1V)1F^WNZ+('&%Y
MF%=6Q 0MF_6G#]))KJ^*P(=EAA)U4N5;E\6;549I6U$PV*4!+MY9721N;!<5
M=0FB,#SG"L$DIN%SOB"GJ&#W8#[)S5@;;7<ES2"%VU_7)$;##\#PMULX??I(
M#%&]N"P_HIC2XZUJ\7ICHMZ][LDN0/T7[2;F0P=[50V3:#Y!*+G'(+D#)<\%
M*D/E5>&:BI6^XHDK3_)+LT,@&&[P@"-\*D=+C*R;H4GD17=%D2=Z[;"6EA>P
M(QL>HF;7E?QWZVRR)FT#@T/%L&Y%08SUO3QOU]S2)#P)@"2KHPE'N46!"1;F
M]%,"-_A<!B<)C7NRFH6T;0K;8%?"U6/<M]0.:K6&=+4+&'0BT-(#Q!\;XTTL
M) ],#.RO6#\/WB S2'.>.]\Z/,;G)1TV:)>  ?@3,.-UFTIOM7IRQ6 OEB[Z
M7%;)%!M<!/X-)0ROC5I-U:Z)N0@>7R:2J39)$Q'A[*+:MLIL#[&O3;L^9VR=
MV2=O<]2"@%J'PZ7#Y+:@6K=",A^=-,\R.)3P!NOB5L4QPQ%Q>2F?!V_+!E<0
M5J1(F5!<-Q>6D0!Q__$:5%VD83[K *+15$ 7D;?L5_W8EMHA2/)3(K<-"0))
M AM,LH CS)3 OEJ\PY;@THA@<EM1B?-*;"^")[$113+^K:.P/Y^P@0$6-(<#
M8^BH'H6CDU*W(#-4AE:F+1QCM.<::\/5A<3;ZKB48&)F[HK<[R'*NML+4;,.
MC SI[FO@[ J,=812 EFK=?]F1#EQ,Y88-]MU[G5@&AGQ)(&.5NH$L<%'*D?_
MVC;M4$A_Q[$;HE'0;$$V(+1".1=1)-K5YBX$+K4Y,FE>P]$&'5:F>ZPD7\[F
M$=P -3R"L+X,".O_/'NF<,0XX[?$Q-_#.6J^A<_?3K_]]EL%$WZXH_ .C5I;
MH.I(8Z\N2A(8BA*( -'JWTFU$F.'TD<?1.SS''TE>&V,:5?4UK3KB*UO>1Q$
M_Y%MJ6%ZKRJV,6!8'9")E,V4B!%2ZUU:XIU-7O@TVGW0CN;0@H$AP(8A<)UH
MYV79&%" 8^;N6K[(WNV3$]PIIG3HK-/;HCC?[7?G>? !"6!AUWFDQ#2E]Z#.
M0ZMU=QN@V7)ZWY7;?',7#,RW;MGI[S-S[3F:EWEMCLS=."BMQAY5J:L9.:J,
MU9'XF&IFA08')9CLTICT=?,/-GRNY#/]I\.)4=S4!\.U]6H-983X#\<LK)05
MC>(%H0T73']KS YJU-9TZYN%RB1IMT*/3,+1*Z^U/NHW\/+S=1;BR<,J"YY
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MYK,X747C<#:.HG ZCZ,D&B^B,,[F\5$VWRN;+P_&\ORK0/@_GF0&3!X-S;L
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M_GB$:T$)-"EYIILLT'F:7%0#>?-W/<^0/]"OX)!I>S^/I3L+A8<O)):TQP5
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M0GDN@1V#'JG7@OKDN"B#,>NTY4$('6E^N$C</TPTD4F$AG;"P&7D+M+/)#'
MA"\ZS0&I27DGE K)>B$_$;!)UQ78L0NHD@WT,;0JG81X>GUL_)QCPX2.@ >1
M\["M6RIK<REKI]Z9%8]NL_?"3R]CP&_6E*P*"O7&8D^K(UCM/K)_9*;X^21<
MCL/Y:BYF<;A(IE$VR>)D/A73.)O/9D?7_'ZF=3AUV'[1#H4CFWH0-D7X8^0M
M5/&R=)P^=BD'H%0W\B??.633TE_L*TYI>"&FH12J*.4?QND<3E6D7>?B;9C>
MO;,3I\;O(-^X5V;A&3[_&*ZQFDP6T6HUG68+&<IQ)L91,@UE-!.3Y62Y$D>N
ML9=K'$X)M'_A!3&LX^",==UT Y@[H19QOG;\7KL<^01.L+!8?+0'5-5\AX)]
M4D.F\RJH1/$120OG87;)B0>/]?UE.55)HG>158A.AS8%QAX"I45VC:L@)PYZ
M;0Q=]3D03I/*A=64><"&JA"1UF^; 'UF#+%TV8Y^2.>,(RP;>NHZW(ZP%7;Z
MG=6\6;KWH"+\JZ7A_80A?:JN0D0V.-(M.WV J3QQ=P]X,'E%G^Y;X3W'9M0#
M@#PH8YB.EV&:)$FZ2$4XR\:KQ601ARNY%./9:B&/P:3[&</A%)[ZH'W!A\82
MSCQ'N).[ .N+<*%"JO[R46Z;T6>5C>\@T%2RG'TEI1P<&GV-I!^S'9 4;$,/
M/9L-@?@4K2V]FGQ^>B3G!Q*%'3L28]UT![P4]45Y12,E$DI45R>=<<L&, TL
MQ$:SE++V,NN87E4V!\?65 7]A/DCWZ5NHRI4[D[=,OG"U!]4\]&;3[<O&Q+J
M!FPVCZJ ]*[C.KK?\ZK>V_F,2<I!H;*9FS6*D*2\,^? 4"I1D1[N!Q7#EI7K
M]N8LA[3?JB7%3 4P><K/WLC>SWA:=8D(<QCI&'?,I4HJ W:)U4ZEXN'JG)&J
MBVQ103'YS.G '3SVW<>="ZNRX"8V*6X=2(2M%HG)K,@MVN/H]&O>1P#+>FU0
M=)A(_=IM%5JJ*EEP-L>,-M^^\9B=OG_(%4+S4.\*D<UHY%9+OH4A?@\$;K"8
M,B<"<)2 2DF:3F19UUY"_(D17&(]<#M)<\ (.(P*P9!HR?Z!6F0@-[8PY/3Z
M=@;TO2+V'6WJW6D]I!P<+2?S\6HB%G$Z#J-E%(7P.5R$JR3,ED(<:\3?$#9\
M.!6Q?C&L\G6.60,0W7J@#N$=D0],-&SZ3<>T;4/0MFU5MX+#'?RJ*7":#(UD
M2%,W:Z655C*S!=;N[>-,7[(!G$77?2\ZE-/-.C8H-WE/D.5%9VEA*WB%2T$2
M>:WK3)55RL)&DI0M6B]L:I M7@Z5WM/6*[<5TH=#"IW2+$Z3>>-:VT%"0:O3
M.F<3%@5"*^ M9OK,ZQAV@2SF\.<YS 4?+EG>2<0V;S MCE3Y0*2H"BLELXCR
MB(3BF_<^E931FKDXEN&I'7_%I5BW>"EK[4Q \9$%-.5' <:=-T/BLDTLJWHH
M,23=W2;-*6]CK^MS>[V/]$+6%NE@-);MA6Q7MS$)LOBH)]BQ;=YDSW+T2 +A
MHW C:PI4<*;.1U?+3DZ.5N_\BWKO]CE2E?T1$S?EK@+AW9Z.</-%Y1I+R>[G
MNAQ1CS^LCJC'SY9TPSA=S6>K^7*Z".-0QLLPG0@Y#66RF*Q6QP0Y-TBZAY,A
M1R5L(_;UGAT@2EIKJUP[A]X1;71HZ\'Y#'NED)CS[6>P>SFH[W K*[_XW@!K
MYQCA_Y@N[6+>.NH802>V&5/M2,L_7%L0HPX+8'UN(L&.4*K2U2A]'J3;3]>C
M@33OGE4$L^&HZ,3*GC-AJZX/O.!4=/5+O5*45%<'Z-13P<#SVAYC?Y;0-:Q7
ME=",%72&I"&*VV+I@ 4%&Y#5[6%+0G3-EDQ1\Q0P?V1Y5<";%_F6YF2'H*L"
M]J;TH%:0)%J)<!8MY5RD%-@U&<_AWPLQ3R/X9WKD#?MYP^$D_GG%^?K5Y3S1
M20H.C?:_+1LD6Z8>M*5*-EUK)T!KM,>O-UC%1!=&<% 5E8/.<'E#4[I0N^L>
MU*Y2:3P>1TVF-V]?G?[\]LWK-R]/SMZ\>QN\>QV\>O/^].79N_<?1H%.+CGZ
M T9V^O,O/[W[G]/3/Z3SD[>O@G=G_SA]'YS\_?3MV8-FUPS',IRMLFB917&(
MD5.)6(19-DD7JW$61L?(WWT;MSB@[)IO@+9N"G9%*B;AUSDZU*P?E)%<R<A8
M(.E*$%W.:\[FK<+YD?SSM\T%U>,IC%>P\QC5K>(,3+I:-?Z4HZVL:'2<L5 @
M[;KETLT6W^ DBM-UC)+\,E^/@J3*-WDAUFC=A@_DJF<= NLI(;*:JI'#%T]$
M@/[^Z?C%+Z9=^F+RXNG(EX')1D?Y## MPX6Q9++A#Q?#+UVU1^MY(@K=K3IM
MR!)MOWHZA$07=6ZLHG:0I/6L@<%*C8WA!>N$%Y$Y42!MQ#1,.X=8F:AN7D;]
M!J@):TD>#!(1=KP_LMC^7%\>'%:1,K+@0E2;M=(INDNA++18M QKD,-1)5A-
M5RT,7OW]Y4\C[46AY*(4_T5K3XJ1A)U"JYA= /00;] .G 9/XK89]9.SJ RI
M]!2GHBF+];4>DQH+;;?_'-Z"#>I$ [-1F;R"N"I%2O6[?'*B=#%HM3 EVU1[
M5.=]3XLRXY)6[E#@M AR?Y#QWXW7V,H"4^1H#PIK@^@B012H<< TL)7H+]"
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MIJ7 3WS+ LLH@W;?&']5M@37<KU@OL/&';*:!;N%S"R9,ZGX<*?RJW:+/0X
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MDX \:.P0HI4-8:$ZTI!%64SAQ 4 "WY;41^)PQ\0'PP)%MK*HDRYEO9D7M$
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M,3 P-#(X,#A?.&LN:'1M4$L! A0#%     @ R$-+5;GUKI$3!@  KQP  !8
M             ( !>Q<  &)R:&,Q,# T,C@P.%]E>#,M,2YH=&U02P$"% ,4
M    " #(0TM5S%!+@\M)  "/]P$ %@              @ '"'0  8G)H8S$P
M,#0R.# X7V5X,RTR+FAT;5!+ 0(4 Q0    ( ,A#2U58N#,@/PD  + I   6
M              "  <%G  !B<FAC,3 P-#(X,#A?97@S+3,N:'1M4$L! A0#
M%     @ R$-+5?E>OG1) P  0 \  !               ( !-'$  &)T>"TR
M,#(R,3 Q,2YX<V102P$"% ,4    " #(0TM5I$ZU;+\(  !A6P  %
M        @ &K=   8G1X+3(P,C(Q,#$Q7VQA8BYX;6Q02P$"% ,4    " #(
M0TM5&GVJ,@,&  #U0   %               @ &<?0  8G1X+3(P,C(Q,#$Q
>7W!R92YX;6Q02P4&      < !P#/ 0  T8,

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
